e51a2f099ecf41b107e04af24bb7c6dd|CXZS2200011|CXZS2200011|苓桂术甘颗粒申请上市技术审评报告.pdf
dcacb2e6a69a5c7ad83362e9aeebec70|CXSS2200037|CXSS2200037|斯鲁利单抗注射液（CXSS2200037）申请上市技术审评报告-.pdf
030c641c2e7333063d6d8be1c825dea9|CXSS2200019|CXSS2200019|瑞基奥仑赛注射液（CXSS2200019）-申请上市技术审评报告.pdf
842343746610916370d1f20703b8d34a|CXHS2200006|CXHS2200006|环泊酚注射液（CXHS2200006） 申请上市技术审评报告.pdf
534dc89db79208881c0175f3fb932a83|CXZS2200001|CXZS2200001|参葛补肾胶囊申请上市技术审评报告.pdf
0f4bfe8a9ec5c12c6bbf289397b056c2|JXHS2200001|JXHS2200001|枸橼酸托法替布缓释片（JXHS2200001）申请上市技术审评报告.pdf
edbef5793e0a198d410844a15bb7f2f6|JXHS2200002|JXHS2200002|枸橼酸托法替布片（JXHS2200002）申请上市技术审评报告.pdf
57d3d849816b83f77a645a4015092901|CXHS2101055|CXHS2101055|甲磺酸伏美替尼片（CXHS2101055）-申请上市技术审评报告.pdf
15ab6fa51e54913028b912178e3eaa3b|CXSS2101059|CXSS2101059|重组人生长激素注射液（CXSS2101059-62）增加适应症技术审评报告.pdf
c978a9384f5be79c0b8677383ec2aeac|CXSS2101060|CXSS2101060|重组人生长激素注射液（CXSS2101059-62）增加适应症技术审评报告.pdf
ef487d5f66705533f3f6c86260ed2512|CXSS2101061|CXSS2101061|重组人生长激素注射液（CXSS2101059-62）增加适应症技术审评报告.pdf
2093c699563c86df577cd3255f1edf7a|CXSS2101062|CXSS2101062|重组人生长激素注射液（CXSS2101059-62）增加适应症技术审评报告.pdf
129a091cc028f8ede0c0c0072006c7d7|CXSS2101057|CXSS2101057|特瑞普利单抗注射液（CXSS2101057-058）-申请上市技术审评报告.pdf
12f00e7bfdb2957360b4cf8c10a59d26|CXSS2101058|CXSS2101058|特瑞普利单抗注射液（CXSS2101057-058）-申请上市技术审评报告.pdf
e465951e320aeaf7a4e64ea6d4a653bc|JXHS2101087|JXHS2101087|注射用曲拉西利 （JXHS2101087）申请上市技术审评报告.pdf
e31307a7f80a0cbf494031c8face1f8d|JXSS2101033|JXSS2101033|帕博利珠单抗注射液（JXSS2101033）公开审评报告-.pdf
16a525326de0d65caae01165cdd57c4b|CXHS2101054|CXHS2101054|环泊酚注射液（CXHS2101054）申请上市技术审评报告.pdf
da590e14c82d91dc1efc2b3ff515dcc1|CXHS2101053|CXHS2101053|注射用苯磺酸瑞马唑仑（CXHS2101053）申请上市技术审评报告.pdf
f5c281083d2354ff610f966c68cc3766|JXHS2101074|JXHS2101074|恩格列净片（JXHS2101074）申请上市技术审评报告.pdf
d47d3bcd64c5a305cfc42663b18fffd2|JXHS2101072|JXHS2101072|恩曲替尼胶囊（JXHS2101072-73）-申请上市技术审评报告.pdf
1161159178ecab9a2f334e1e17510987|JXHS2101073|JXHS2101073|恩曲替尼胶囊（JXHS2101072-73）-申请上市技术审评报告.pdf
680d190e05be97265465b412cd18c42e|JXHS2101068|JXHS2101068|塞普替尼胶囊（JXHS2101068-069）申请上市注册申请技术审评报告_.pdf
49351e2ad3b9d48204537ccc6c4285a1|JXHS2101069|JXHS2101069|塞普替尼胶囊（JXHS2101068-069）申请上市注册申请技术审评报告_.pdf
ed4f2e4632976fdd182fb48a32b1237c|JXHS2101070|JXHS2101070|塞普替尼胶囊（JXHS2101070-071）申请上市注册申请技术审评报告.pdf
cbf23ce75faa180b0b33706614cac145|JXHS2101071|JXHS2101071|塞普替尼胶囊（JXHS2101070-071）申请上市注册申请技术审评报告.pdf
dac1ebab4d4c425bcb2d7cc57e7703d6|CXSS2101045|CXSS2101045|信迪利单抗注射液（CXSS2101045）申请上市技术审评报告-.pdf
7f0b48a92aa808f5d45012d29b77a9ae|CXHS2101050|CXHS2101050|瑞维鲁胺片（CXHS2101050）申请上市技术审评报告-.pdf
a9b4dbf79cb64760b1d0318df96aeca9|JXHS2101063|JXHS2101063|恩曲替尼胶囊（JXHS2101063-064）-申请上市技术审评报告.pdf
60c80b63b1da553f4e2be26ccb079cdc|JXHS2101064|JXHS2101064|恩曲替尼胶囊（JXHS2101063-064）-申请上市技术审评报告.pdf
add726d09fcccc62da85fd9893bf1ea5|CXSS2101041|CXSS2101041|普特利单抗注射液（CXSS2101041）公开审评报告-.pdf
23fffd5af0aebfb5279a29c3476b9002|CXHS2101048|CXHS2101048|甲苯磺酸多纳非尼片（CXHS2101048）公开审评报告-.pdf
ce4636d05254d9ae5be8cf6d78d2a038|CXSS2101036|CXSS2101036|重组人生长激素注射液（CXSS2101036-039）增加适应症技术审评报告.pdf
015f2246f472f2ad1f46d368eb071d92|CXSS2101037|CXSS2101037|重组人生长激素注射液（CXSS2101036-039）增加适应症技术审评报告.pdf
e3fc569f0e2310dfb61148a1866d9233|CXSS2101038|CXSS2101038|重组人生长激素注射液（CXSS2101036-039）增加适应症技术审评报告.pdf
8c4bf333f2b508d1f0592d36d41d2d3a|CXSS2101039|CXSS2101039|重组人生长激素注射液（CXSS2101036-039）增加适应症技术审评报告.pdf
4ce678a0a9384fc3b17b7c96e88f98c7|CXSS2101032|CXSS2101032|卡度尼利单抗注射液（CXSS2101032）申请上市技术审评报告.pdf
92e0cfd9f49f5295512a7ef056a01b6f|JXSS2101023|JXSS2101023|依奇珠单抗注射液 （JXSS2101023）申请上市技术审评报告.pdf
f0b79c50e4661f89a874b06c8549c7a0|CXSS2101031|CXSS2101031|信迪利单抗注射液（CXSS2101031）申请上市技术审评报告-.pdf
dfa459a17d5ef67df57063f5cf7909b4|CXSS2101030|CXSS2101030|斯鲁利单抗注射液（CXSS2101030）申请上市技术审评报告-.pdf
e1bd3af2d1b0a8e7891e3c0ffa2ca2f9|JXSS2101022|JXSS2101022|纳武利尤单抗注射液（JXSS2101021-22）报告.pdf
33a43002d7e5a5468b65a69d4d74b262|JXSS2101019|JXSS2101019|纳武利尤单抗注射液（JXSS2101019-20）申请上市技术审评报告.pdf
db03dde5c2ef6ca0f7e405d549813ebe|JXSS2101020|JXSS2101020|纳武利尤单抗注射液（JXSS2101019-20）申请上市技术审评报告.pdf
928ac6d69c7a891235f9956b24886b68|JXSS2101021|JXSS2101021|纳武利尤单抗注射液（JXSS2101021-22）报告.pdf
cc1ed1b72e223b157589e419588ccda9|CXHS2101037|CXHS2101037|示踪用盐酸米托蒽醌注射液（CXHS2101037）申请上市技术审评报告-.pdf
feed71b664aebcf532dfdc1b0d2683d9|CXSS2101026|CXSS2101026|舒格利单抗注射液（CXSS2101026）申请上市技术审评报告-.pdf
9ef4e1c382a877748a8e4b7bccf70af5|JXHS2101043|JXHS2101043|曲美替尼片（JXHS2101043-044）-申请上市技术审评报告.pdf
748b2a8038d02e609c2282201dff0b4c|JXHS2101044|JXHS2101044|曲美替尼片（JXHS2101043-044）-申请上市技术审评报告.pdf
ce1cf85e143a879c0c70be7756b3c372|JXHS2101045|JXHS2101045|甲磺酸达拉非尼胶囊（JXHS2101045-046）-申请上市技术审评报告.pdf
06d1d6aaf276ab60bdb3f59ab49bd4c0|JXHS2101046|JXHS2101046|甲磺酸达拉非尼胶囊（JXHS2101045-046）-申请上市技术审评报告.pdf
0c4548ea3cfae843d6ba014cf7ba7d74|CXHS2101036|CXHS2101036|妥布霉素吸入溶液（CXHS2101036） 申请上市技术审评报告.pdf
84a5bb561aaa627b142ef9d86a217a57|JXHS2101047|JXHS2101047|贝米肝素钠注射液（JXHS2101047-48）申请上市技术审评报告.pdf
5245b806d8cd273a632227cdcdcd7f9f|JXHS2101048|JXHS2101048|贝米肝素钠注射液（JXHS2101047-48）申请上市技术审评报告.pdf
933d4c8dab1f114606dc1fe8d8983531|JXSS2101017|JXSS2101017|雷莫西尤单抗注射液（JXSS2101017-18）申请上市技术审评报告-.pdf
0aa91c2f25ec676d9e696584f04266bd|JXSS2101018|JXSS2101018|雷莫西尤单抗注射液（JXSS2101017-18）申请上市技术审评报告-.pdf
8f9b6e46d3baf57f60b9278460734308|CXSS2101021|CXSS2101021|替雷利珠单抗注射液（CXSS2101021）申请上市技术审评报告-.pdf
db54fcef913169f7820e05420865585d|JXHS2101039|JXHS2101039|艾伏尼布片（JXHS2101039）-申请上市技术审评报告.pdf
10e7f463bef46b50e32f4bb89f461faa|CXSS2101014|CXSS2101014|特瑞普利单抗注射液（CXSS2101014-15）申请上市技术审评报告.pdf
8efb2b681ace7bc8329b17f486d09d46|CXSS2101015|CXSS2101015|特瑞普利单抗注射液（CXSS2101014-15）申请上市技术审评报告.pdf
81cd1e6a80926fcb2d6a030829a159fc|JXHS2101035|JXHS2101035|丁甘交联玻璃酸钠注射液（JXHS2101035）申请上市技术审评报告.pdf
7e1b0088b78a472f9eb3f5aa7bfb94ed|CXHS2101030|CXHS2101030|依达拉奉舌下片（CXHS2101030）申请上市技术审评报告.pdf
0ddd99191dbd441b76aeeb0f89448ed9|JXHS2101033|JXHS2101033|拉米夫定多替拉韦片（JXHS2101033）申请上市技术审评报告.pdf
68277b24de378cfd7c9fd388719246dd|CXSS2101011|CXSS2101011|CXSS2101011_注射用维迪西妥单抗_报告.pdf
f4be24ce20566cab29bfd1e076125b44|JXHS2101031|JXHS2101031|Lorlatinib片（JXHS2101031-32）申请上市技术审评报告-.pdf
87c83c20b238aef5bc90a6afc35c31d0|JXHS2101032|JXHS2101032|Lorlatinib片（JXHS2101031-32）申请上市技术审评报告-.pdf
f55d7ba34ff0fc95ea99d0b7e534062d|CXHS2101028|CXHS2101028|CXHS2101028-29_盐酸恩沙替尼胶囊_报告.pdf
f77c2aaa48479296f694e29d9548009c|CXHS2101029|CXHS2101029|CXHS2101028-29_盐酸恩沙替尼胶囊_报告.pdf
52f259405b2615edd87cbec39f7712ea|CXSS2101010|CXSS2101010|门冬胰岛素50注射液（CXSS2101010）申请上市技术审评报告.pdf
a431071cf723c285301a12dbbb6dbeb0|JXHS2101026|JXHS2101026|JXHS2101026 28_Pemigatinib片_报告_.pdf
d53b87e5fe60e02825a62aceb39bd87f|JXHS2101028|JXHS2101028|JXHS2101026 28_Pemigatinib片_报告_.pdf
ea0ce1a41fad21af6378efbb66eaae94|CXSS2101009|CXSS2101009|替雷利珠单抗注射液（CXSS2101009）-申请上市技术审评报告.pdf
3889d1b314195592c0f3de4fc5ec1d0a|CXSS2101008|CXSS2101008|普特利单抗注射液（CXSS2101008）公开审评报告_.pdf
309f66d923f200c6d9a11ed470e9e7e0|CXZS2101003|CXZS2101003|广金钱草总黄酮胶囊申请上市技术审评报告.pdf
afe354ecebdfbf60876d067e90700d9f|JXSS2101015|JXSS2101015|莫格利珠单抗注射液 （JXSS2101015）申请上市公开审评报告.pdf
0e9059b6d1ff969a7011fb8bcc68a153|CXHS2101026|CXHS2101026|CXHS2101026_注射用苯磺酸瑞马唑仑 报告.pdf
41aff80c2c75482eb241a8b6c5aaef2c|JXSS2101014|JXSS2101014|JXSS2101014_阿替利珠单抗注射液_报告.pdf
037c258a2799a042114576ce5ea98d77|CXHS2101025|CXHS2101025|环泊酚注射液 （CXHS2101025）-申请上市技术审评报告.pdf
1a81e6f834b1ee4960ec7b732e7dfa0d|CXSS2101004|CXSS2101004|替雷利珠单抗注射液（CXSS2101004）申请上市技术审评报告.pdf
6a0d080093676ea898731d2407c1e93c|CXHS2101017|CXHS2101017|CXHS2101017_甲磺酸阿美替尼片_报告.pdf
64fb046d909803a6ba92a71091ef2058|JXHS2101014|JXHS2101014|硫酸拉罗替尼口服溶液（JXHS2101014）申请上市技术审评报告-.pdf
c3b820104b610cba7555acd3d500f372|JXHS2101015|JXHS2101015|硫酸拉罗替尼胶囊（JXHS2101015-16）申请上市技术审评报告-.pdf
8c5549200894a3cc837e612d5066a481|JXHS2101016|JXHS2101016|硫酸拉罗替尼胶囊（JXHS2101015-16）申请上市技术审评报告-.pdf
923cbd0d1dc053e39366d75672517427|JXSS2101007|JXSS2101007|注射用戈沙妥珠单抗（JXSS2101007）-申请上市技术审评报告.pdf
d8073aa63d86a0740e7bba7625d5a140|CXHS2101013|CXHS2101013|林普利塞片（CXHS2101013）申请上市公开审评报告.pdf
891006bf432a34d4e9246e7e4126b016|JXSS2101005|JXSS2101005|JXSS2101005-6.pdf
55d0410c0368dd9a7284036ad75053e7|JXSS2101006|JXSS2101006|JXSS2101006.pdf
6c8cd5de001bff7230046810130f806c|CXHS2101010|CXHS2101010|CXHS2101010-12_盐酸安罗替尼胶囊_报告_.pdf
dce08325fa8bad3fca4e7948415920f5|CXHS2101011|CXHS2101011|CXHS2101010-12_盐酸安罗替尼胶囊_报告_.pdf
f5f7a291ab5013d2ae4caebbfd138e6d|CXHS2101012|CXHS2101012|CXHS2101010-12_盐酸安罗替尼胶囊_报告_.pdf
30d539ecf206141214c36afa828563e5|CXHS2101006|CXHS2101006|羟乙磺酸达尔西利片 （CXHS2101006-8）-申请上市技术审评报告.pdf
72026c777950241733147ad8a659ec5d|CXHS2101007|CXHS2101007|羟乙磺酸达尔西利片 （CXHS2101006-8）-申请上市技术审评报告.pdf
e13d6d180d3c229b293bd9b913d235a4|CXHS2101008|CXHS2101008|羟乙磺酸达尔西利片 （CXHS2101006-8）-申请上市技术审评报告.pdf
6ce0d77e6dd3254ced6aa31be84d4c1c|CXHS2101004|CXHS2101004|多格列艾汀片（CXHS2101004）申请上市技术审评报告.pdf
257a6ed6cb546398e81fd45ac33477ce|CXSS2101000|CXSS2101000|斯鲁利单抗注射液（CXSS2101000）-申请上市技术审评报告.pdf
572d42f871a5adc7c3e4932d5c503bca|JXHS2101007|JXHS2101007|依维莫司片（JXHS2101007-9）-申请上市技术审评报告.pdf
99abcf6bfecfaca5c9b4f474443f0297|JXHS2101008|JXHS2101008|依维莫司片（JXHS2101007-9）-申请上市技术审评报告.pdf
0b5445291a230aba64e1e3ab1819f862|JXHS2101009|JXHS2101009|依维莫司片（JXHS2101007-9）-申请上市技术审评报告.pdf
f1bbd741b91562367c1f97726b74f957|JXHS2101010|JXHS2101010|hbs.pdf
9d091422a420a515a940e3ba357bd09d|JXHS2101004|JXHS2101004|度维利塞胶囊（JXHS2101004-05） 申请上市技术审评报告.pdf
699a8058ead5a6c602c866aa157fabca|JXHS2101005|JXHS2101005|度维利塞胶囊（JXHS2101004-05） 申请上市技术审评报告.pdf
582b78bd368c33b41fafad4060f57f61|JXHS2101002|JXHS2101002|Lorlatinib片（JXHS2101002、3）技术审评报告-.pdf
c1f60d13689c76289e48989a60611862|JXHS2101003|JXHS2101003|Lorlatinib片（JXHS2101002、3）技术审评报告-.pdf
afaf6562c55b2e7e38087816aedf1e21|CXZS2101001|CXZS2101001|淫羊藿素软胶囊申请上市技术审评报告.pdf
81d9741607fdeb177e4f149933d1a435|JXSS2101003|JXSS2101003|奥马珠单抗注射液（JXSS2101003）申请上市技术审评报告.pdf
f519839a3c2ae171a12d104aa83ca985|JXHS2100035|JXHS2100035|氟轻松玻璃体内植入剂-更新版.pdf
7283e1ac5a0d8172bfdbb408420039bd|JXSS2100023|JXSS2100023|贝伐珠单抗注射液（JXSS2100023）申请上市技术审评报告.pdf
6231eaf0b79429c5340b9ada94e3466b|JXSS2100021|JXSS2100021|贝伐珠单抗注射液（JXSS2100021）申请上市技术审评报告.pdf
802ee19fbe2e21c175907bb88e731799|JXSS2100020|JXSS2100020|注射用贝林妥欧单抗（JXSS2100020）-申请上市技术审评报告.pdf
edbaaf790d8a7f5bbb5bd08d303e24d1|JXHS2101001|JXHS2101001|JXHS2101001_普拉替尼胶囊_报告_.pdf
25921939e34edb3dac363634ba33fca8|CXSS2100031|CXSS2100031|注射用卡瑞利珠单抗（CXSS2100031）-申请上市技术审评报告.pdf
0f1205af3cd18f16bdbc7980e1a6e43e|CXSS2100032|CXSS2100032|CXSS2100032_注射用卡瑞利珠单抗_上市药品公示报告.pdf
7f91c48ed1c966a75f4789ffe23bbd7e|CXZS2100007|CXZS2100007|解郁除烦胶囊（CXZS2100007）申请上市技术审评报告.pdf
581d80c33b4863e7984ede187e718b44|CXSS2100030|CXSS2100030|CXSS2100030_替雷利珠单抗注射液_报告.pdf
3e35cc7345b33e0eaeabb6ef174ae89a|CXSS2100028|CXSS2100028|注射用人干扰素γ（CXSS2100028、29）申请上市技术审评报告.pdf
0f4fa3ac07a6b4aa5ce3cebfba84afa6|CXSS2100029|CXSS2100029|注射用人干扰素γ（CXSS2100028、29）申请上市技术审评报告.pdf
5ea5fe28434a2f1244c0008b33be724f|CXSS2100025|CXSS2100025|门冬胰岛素注射液（CXSS2100025）申请上市技术审评报告.pdf
a506ad45f69f5fa97833171b0c4cf19b|JXHS2100023|JXHS2100023|JXHS2100023_磷酸索尼德吉胶囊_报告_.pdf
3351efb34e8ba9f709e59e7572f64904|JXSS2100015|JXSS2100015|达雷妥尤单抗注射液（JXSS2000015-16）-申请上市技术审评报告.pdf
20f00a71551f8a2c3c88e2c88b2f091c|JXSS2100016|JXSS2100016|达雷妥尤单抗注射液（JXSS2000015-16）-申请上市技术审评报告.pdf
6b8602a1b24b321c6cab89959969a4aa|CXSS2100016|CXSS2100016|特瑞普利单抗注射液（CXSS2100016）-申请上市技术审评报告.pdf
57136b8cce7e6d147ae060a793b00468|CXSS2100017|CXSS2100017|特瑞普利单抗注射液（CXSS2100017）-申请上市技术审评报告.pdf
46f77751218d247c01f13ab0d66c5ec4|CXSS2100018|CXSS2100018|特瑞普利单抗注射液（CXSS2100018）-申请上市技术审评报告.pdf
ca7e8856ead0122789d2ef69a7664d1d|CXSS2100019|CXSS2100019|门冬胰岛素30注射液（CXSS2100019）申请上市技术审评报告.pdf
fd4f9c5e1b0c70872eacb3f088fa87ad|JXHS2100020|JXHS2100020|阿布昔替尼片-更新版.pdf
05e6987fa1212a91d3c05e0dc760dbea|JXHS2100021|JXHS2100021|阿布昔替尼片-更新版.pdf
f70be8c77ea8d01cd52c6223b0b67cfc|JXHS2100022|JXHS2100022|阿布昔替尼片-更新版.pdf
77ca5a16672f391a429f0506701e2850|CXHS2100004|CXHS2100004|注射用甲苯磺酸瑞马唑仑（CXHS2100004） 申请上市技术审评报告.pdf
3f41db98c8aedda2c51a37acfd08b10d|CXHS2100003|CXHS2100003|环泊酚注射液（CXHS2100003）-申请上市技术审评报告.pdf
4fe35d064f50cf69f143311eff54abd5|JXSS2100010|JXSS2100010|注射用罗特西普（JXSS2100010-11）-申请上市技术审评报告.pdf
6175d6a48315604e1c1e8fd18816cb94|JXSS2100011|JXSS2100011|注射用罗特西普（JXSS2100010-11）-申请上市技术审评报告.pdf
bfd6a1d227bd0b35dc96499ccff6edd6|JXHS2100014|JXHS2100014|阿普米司特片14.pdf
3fdc9b8dabf5f34c0c6f62cedb35deca|JXHS2100015|JXHS2100015|阿普米司特片14.pdf
7bfa63426badfd23e13f75d976579870|JXHS2100016|JXHS2100016|阿普米司特片14.pdf
81c3ebb700ff18be65deb5720a46d1f5|JXHS2100017|JXHS2100017|非奈利酮片（JXHS2100017-18）申请上市技术审评报告.pdf
56fb6985cc97434266dce47adbbe9a92|JXHS2100018|JXHS2100018|非奈利酮片（JXHS2100017-18）申请上市技术审评报告.pdf
07e996aeda24b82d8bff917b544ab088|JXHS2100012|JXHS2100012|注射用奥沙利铂 （JXHS2100012）-申请上市技术审评报告.pdf
d4e2b6fffe64929796611bf092ce4e91|JXHS2100013|JXHS2100013|塞利尼索片（JXHS2100013）-申请上市技术审评报告.pdf
c3385261820e6e4c596db87fb06ec90c|JXHS2100011|JXHS2100011|枸橼酸托法替布片（JXHS2100011）申请上市技术审评报告.pdf
b912a6087d50f1a5380abf53e3a2b113|JXHS2100009|JXHS2100009|达格列净片（JXHS2100009-10）申请上市技术审评报告.pdf
90625aac31dd10dde89f0136267a7574|JXHS2100010|JXHS2100010|达格列净片（JXHS2100009-10）申请上市技术审评报告.pdf
fa164b57a635dd1616d3fbc828d9e13e|JXHS2100006|JXHS2100006|布格替尼片（JXHS2100006-008）申报上市注册申请技术审评报告-.pdf
d2c4bd40621b0a21a8b58038fa25b566|JXHS2100007|JXHS2100007|布格替尼片（JXHS2100006-008）申报上市注册申请技术审评报告-.pdf
53a312a315462eb698c7bcbf85ab9242|JXHS2100008|JXHS2100008|布格替尼片（JXHS2100006-008）申报上市注册申请技术审评报告-.pdf
db2cd0cbf570591739ed623c57c16d8c|JXSS2100006|JXSS2100006|雷莫西尤单抗注射液（JXSS2100006-7）申请上市技术审评报告.pdf
86534e832380675f1c0f4c3efd365339|JXSS2100007|JXSS2100007|雷莫西尤单抗注射液（JXSS2100006-7）申请上市技术审评报告.pdf
9ec502694dda554feed2522459cd63b5|JXHS2100005|JXHS2100005|氨吡啶缓释片 （JXHS2100005）申请上市技术审评报告.pdf
86db75bd9594b86ad190ac0ae0839d38|JXSS2100004|JXSS2100004|注射用司妥昔单抗（JXSS2100004-05）申请上市技术审评报告.pdf
fae03b42d011adf4a6e47d5745f85696|JXSS2100005|JXSS2100005|注射用司妥昔单抗（JXSS2100004-5）申请上市技术审评报告.pdf
75d1db747c44089aa4afcbc63c8e0e79|CXSS2100011|CXSS2100011|特立帕肽注射液（CXSS2100011）申请上市技术审评报告.pdf
e121c152dad643d1341ce14c5df54256|CXHS2000047|CXHS2000047|替戈拉生片（CXHS2000047）申请上市技术审评报告.pdf
db0d22bef0640b96bbe8da02b5211bb6|JXSS2100003|JXSS2100003|amz.pdf
12594b3c0023807f5fdec090ef4be2ab|CXSS2100008|CXSS2100008|贝伐珠单抗注射液 （CXSS2100008）-申请上市技术审评报告.pdf
f8672ff7a6932a553850d412c961d2ef|CXSS2100009|CXSS2100009|CXSS2100009_信迪利单抗注射液_报告_.pdf
339ba5aaf0bdad521af92cb9896acc35|JXHS2100004|JXHS2100004|乌帕替尼缓释片（JXHS2100004）申请上市技术审评报告.pdf
3528be868dfc20e66679fe9b140a61d5|JXHS2100001|JXHS2100001|奥拉帕利片（JXHS2100001-2）申请上市技术审评报告 公布版.pdf
7a8e7e703461978007347d1af5336f5b|CXSS2100001|CXSS2100001|注射用重组人生长激素（CXSS2100001-06）-申请上市技术审评报告.pdf
d886f2bade08044ac3a98aef8e7923b0|CXSS2100002|CXSS2100002|注射用重组人生长激素（CXSS2100001-06）-申请上市技术审评报告.pdf
5ea457e04c166a90945a92d4cba3f99f|CXSS2100003|CXSS2100003|注射用重组人生长激素（CXSS2100001-06）-申请上市技术审评报告.pdf
bad96ba78f066c5dad40ca1666527a54|CXSS2100004|CXSS2100004|注射用重组人生长激素（CXSS2100001-06）-申请上市技术审评报告.pdf
4e0ab4cd85ba33724c0d22a6f001144d|CXSS2100005|CXSS2100005|注射用重组人生长激素（CXSS2100001-06）-申请上市技术审评报告.pdf
c0c4d514209eafa77f8ac5a593873193|CXSS2100006|CXSS2100006|注射用重组人生长激素（CXSS2100001-06）-申请上市技术审评报告.pdf
78c27774cf3727a76eb42a41cc4303a7|JXHS2100002|JXHS2100002|奥拉帕利片（JXHS2100001-2）申请上市技术审评报告 公布版.pdf
dabc0dae1d4dc87e971c9c5255610381|JXSS2000068|JXSS2000068|JXSS2000068_贝伐珠单抗注射液_报告_.pdf
2a523ef0a2b603cf811d4908f416f8c8|CXZS2000010|CXZS2000010|坤心宁颗粒申请上市技术审评报告.pdf
8054f0c8ebf19443d68c3f6ddb028868|JXHS2000188|JXHS2000188|乌帕替尼缓释片（JXHS2000188）申请上市技术审评报告.pdf
093c27ec23f68f74082822a29763144c|CXZS2000009|CXZS2000009|七蕊胃舒胶囊（CXZS2000009）申请上市技术审评报告.pdf
73f7440d1e3a1d692d00ef7a88486d42|JXHS2000182|JXHS2000182|阿贝西利片（JXHS2000182-184）-申请上市技术审评报告.pdf
9c91a015dc7a48041523bb059e0d84d7|JXHS2000183|JXHS2000183|阿贝西利片（JXHS2000182-184）-申请上市技术审评报告.pdf
3204432f3d5214169ae8137fe073864b|JXHS2000184|JXHS2000184|阿贝西利片（JXHS2000182-184）-申请上市技术审评报告.pdf
776cc1d8d80b80397f04064c4e3a0ecc|JXHS2000186|JXHS2000186|乌帕替尼缓释片（JXHS2000186-7).pdf
91c2d5a5dfb1a3632c9f709ca66e9d55|JXHS2000187|JXHS2000187|乌帕替尼缓释片（JXHS2000186-7).pdf
407a7e4f272155c8422c24844bb5fc84|JXSS2000066|JXSS2000066|JXSS2000066-67_纳武利尤单抗注射液_报告.pdf
3c65fe04bbb8607c0507c85ebd85bb92|JXSS2000067|JXSS2000067|JXSS2000066-67_纳武利尤单抗注射液_报告.pdf
3ae7df45b6395e730b634371b0d6aa78|CXHS2000046|CXHS2000046|氟唑帕利胶囊（CXHS2000046）-申请上市技术审评报告.pdf
6639cfdaef1eff2ace65394ece2d712d|CXSS2000059|CXSS2000059|利妥昔单抗注射液（CXSS2000059）申请上市技术审评报告.pdf
73b7319a7435cfe8f95e3c2b30de79c1|CXZS2000008|CXZS2000008|芪蛭益肾胶囊申请上市技术审评报告.pdf
952d050dd358172f0c94db59a4375a85|CXSS2000060|CXSS2000060|恩沃利单抗注射液（CXSS2000060）-申请上市技术审评报告.pdf
3a908f4ce7da11310000ed48dba85c16|JXHS2000173|JXHS2000173|泊沙康唑注射液（JXHS2000173）.pdf
3465b09937ff24140653968d6cc751c3|JXHS2000174|JXHS2000174|泊沙康唑肠溶片 （JXHS2000174）.pdf
addf335d2923e7eeea4791785ac3a81c|JXHS2000175|JXHS2000175|利伐沙班片 （JXHS2000175）申请上市技术审评报告.pdf
83e8286643b3f56ebf774092add9f073|JXSS2000063|JXSS2000063|帕博利珠单抗注射液 （JXSS2000063）-申请上市技术审评报告.pdf
955ff4147866cff8225ca22b2077bc7b|JXSS2000058|JXSS2000058|依马利尤单抗注射液（JXSS2000058-60）申请上市技术审评报告.pdf
b00f5049d62f16774863bd80eaa17270|JXSS2000059|JXSS2000059|依马利尤单抗注射液（JXSS2000058-60）申请上市技术审评报告.pdf
d5294a9d6719fb1a729d8f09545c32f2|JXSS2000060|JXSS2000060|依马利尤单抗注射液（JXSS2000058-60）申请上市技术审评报告.pdf
c52400e9b902afbd2aa435e1d5c1e76f|JXSS2000061|JXSS2000061|注射用贝利尤单抗（JXSS2000061、62）申请上市技术审评报告.pdf
6a53932eab3b2d8843a2b346b10a419c|JXSS2000062|JXSS2000062|注射用贝利尤单抗（JXSS2000061、62）申请上市技术审评报告.pdf
76b5d02db76a24bea99e19f7dccd33a2|JXSS2000053|JXSS2000053|纳武利尤单抗注射液（JXSS2000053-54）申请上市技术审评报告-定稿.pdf
582f383674a41fce46d2c0acd9ec2d83|JXSS2000054|JXSS2000054|纳武利尤单抗注射液（JXSS2000053-54）申请上市技术审评报告-定稿.pdf
380ee7f499172265d4001ceebbddfa92|JXSS2000055|JXSS2000055|伊匹木单抗注射液 （JXSS2000055-56）申请上市技术审评报告-定稿.pdf
f69a88205f7cda332092f49151f7f22e|JXSS2000056|JXSS2000056|伊匹木单抗注射液 （JXSS2000055-56）申请上市技术审评报告-定稿.pdf
15018fd5d62426d8baaf7f4fc06a34c5|CXZS2000007|CXZS2000007|玄七健骨片（CXZS2000007）申请上市技术审评报告.pdf
b76a718fc80af62c0e2aa69024c24906|CXZS2000006|CXZS2000006|虎贞清风胶囊（CXZS2000006）申请上市技术审评报告.pdf
7ebd2bc4af99d51d249d4497a1fc2c29|CXSS2000058|CXSS2000058|甘精胰岛素注射液（CXSS2000058）申请上市技术审评报告.pdf
e6a8dba06440bb08ba86312451164d13|JXHS2000170|JXHS2000170|钇[90Y]微球注射液（JXHS2000170）-申请上市技术审评报告.pdf
d2cc2213099e68522ca6ed06232bf937|JXSS2000051|JXSS2000051|帕博利珠单抗注射液（JXSS2000051）申请上市技术审评报告.pdf
b2ee8d0f37c713fa31befde35520768f|JXHS2000169|JXHS2000169|硫酸艾沙康唑胶囊 （JXHS2000169）申请上市技术审评报告.pdf
a75beef31b821202d951760b0f2b1673|JXHS2000165|JXHS2000165|来特莫韦片（JXHS2000165-166）申请上市技术审评报告.pdf
e617c4cb87c6c2eb5bc95d1ee5e74df7|JXHS2000166|JXHS2000166|来特莫韦片（JXHS2000165-166）申请上市技术审评报告.pdf
52a418f0ebda04869aaf5e057a6f05cc|JXHS2000168|JXHS2000168|恩格列净片 （JXHS2000168）申请上市技术审评报告.pdf
ed2216fac53d854d4f886e0589501643|CXSS2000056|CXSS2000056|CXSS2000056_舒格利单抗注射液_报告_.pdf
344b2bb12cbce1c19be585f2a710dfea|CXSS2000055|CXSS2000055|CXSS2000055_注射用卡瑞利珠单抗_上市药品公示报告.pdf
7439bb03b68c61de4ee0c5bf08407a7b|CXZS2000005|CXZS2000005|银翘清热片（CXZS2000005）申请上市技术审评报告.pdf
f8598cf4eab319b819c9a5150a52f7c1|JXHS2000160|JXHS2000160|JXHS2000160-61_注射用盐酸吉西他滨_上市药品公示报告.pdf
5f21464b298233bdce953ce21f5f72b1|JXHS2000161|JXHS2000161|JXHS2000160-61_注射用盐酸吉西他滨_上市药品公示报告.pdf
360c372ae5cf4cf21caa1c8067aebfa2|JXSS2000050|JXSS2000050|达雷妥尤单抗注射液（皮下注射）（JXSS2000050）-申请上市技术审评报告.pdf
cf24d254feb5b8f714dfd09c43655318|JXSS2000049|JXSS2000049|奥法妥木单抗注射液 （JXSS2000049）申请上市技术审评报告.pdf
818c4cb1c5f006f21d23c989548cd2c3|CXSS2000054|CXSS2000054|注射用英夫利西单抗（CXSS2000054）申请上市技术审评报告.pdf
779d915b58271fe32234e2b0c866b445|JXSS2000048|JXSS2000048|JXSS2000048_迪妥昔单抗注射液_报告.pdf
853fc64295a5edbade5e1ff091588a1f|JXHS2000158|JXHS2000158|倍氯福格吸入气雾剂（JXHS2000158）     申请上市技术审评报告.pdf
426e7514f3a640710b0911388d6cc304|CXHS2000040|CXHS2000040|阿立哌唑口溶膜（CXHS2000040-41）-申请上市技术审评报告.pdf
a3158b57d8d554692336f5fa2466a530|CXHS2000041|CXHS2000041|阿立哌唑口溶膜（CXHS2000040-41）-申请上市技术审评报告.pdf
26d73c797e0769890a657c24d651b5a3|JXHS2000157|JXHS2000157|JXHS2000157.pdf
e9b5c85da68ae1b5301dce0f8347b232|CXSS2000052|CXSS2000052|甘精胰岛素注射液（CXSS2000052）申请上市技术审评报告.pdf
cad731fcbabd2e96adc3f14a5edf9c3f|CXSS2000053|CXSS2000053|重组人生长激素注射液（CXSS2000053）增加适应症技术审评报告.pdf
465e9a80282e93c0c6727e3dea626ac0|JXHS2000153|JXHS2000153|吡仑帕奈片（JXHS2000153、54）申请上市技术审评报告.pdf
e38ff9878fb687f3949cf990c382e397|JXHS2000154|JXHS2000154|吡仑帕奈片（JXHS2000153、54）申请上市技术审评报告.pdf
42bb9286997f45232885f590e90a821a|JXHS2000155|JXHS2000155|吡仑帕奈片（JXHS2000155、56）申请上市技术审评报告.pdf
a16bcd30bd7d0dbc116a6816008ec450|JXHS2000156|JXHS2000156|吡仑帕奈片（JXHS2000155、56）申请上市技术审评报告.pdf
ad2f0a0df9cd569126c6e9c6d6f8dd8a|JXSS2000042|JXSS2000042|伊奈利珠单抗注射液（JXSS2000042）申请上市技术审评报告.pdf
e03c37df1641197b29283bcea1a6db4d|JXSS2000044|JXSS2000044|JXSS2000047-44.pdf
066ecaf6bdcf87acaa36bb14f231296c|JXSS2000045|JXSS2000045|JXSS2000047-44.pdf
c5d9944f0f0bdbf94e1164d7e12b557d|JXSS2000046|JXSS2000046|JXSS2000047-44.pdf
34b2ab8eecb603efac90999d67eef96d|JXSS2000047|JXSS2000047|JXSS2000047-44.pdf
ad72e1c11102be05ccfaaeb0b8edb567|JXSS2000039|JXSS2000039|布罗索尤单抗注射液（JXSS2000039-41）-申请上市技术审评报告.pdf
0cccd69568993165c2ce53de7b1a5127|JXSS2000040|JXSS2000040|布罗索尤单抗注射液（JXSS2000039-41）-申请上市技术审评报告.pdf
2965cdf31fc4e9d0987b12265953fc87|JXSS2000041|JXSS2000041|布罗索尤单抗注射液（JXSS2000039-41）-申请上市技术审评报告.pdf
24cf0aa38ed5c93ca141542c16db7c6a|CXHS2000038|CXHS2000038|奥雷巴替尼片（CXHS2000038）-申请上市技术审评报告.pdf
fdbef1e30e3b4211e4d434ea788e83c2|JXSS2000038|JXSS2000038|JXSS2000038.pdf
e748e9219716a3919c724d62d0bc1594|CXHS2000035|CXHS2000035|脯氨酸恒格列净片（CXHS2000035-036）  申请上市技术审评报告.pdf
f57179829692f4b82caeb3209d91207b|CXHS2000036|CXHS2000036|脯氨酸恒格列净片（CXHS2000035-036）  申请上市技术审评报告.pdf
7d232c7dd78461d181518ffbd5e53e82|CXHS2000037|CXHS2000037|泽布替尼胶囊（CXHS2000037）-申请上市技术审评报告.pdf
e99f263157c68f5ed71c2922b1cc7882|JXHS2000150|JXHS2000150|JXHS2000150_甲磺酸奥希替尼片_上市药品公示报告.pdf
ced3e12515268389333df5ef59781153|JXHS2000151|JXHS2000151|JXHS2000151_甲磺酸奥希替尼片_上市药品公示报告.pdf
5c1e527324df999efe5df1f14231d110|JXSS2000034|JXSS2000034|JXSS2000034.pdf
0139221ce453f55658751b1cbe0e90cf|JXSS2000035|JXSS2000035|JXSS2000034.pdf
9c0ee75ef8613154fad7263d9e5ac92d|JXSS2000036|JXSS2000036|德谷胰岛素利拉鲁肽注射液（JXSS2000036）申请上市技术审评报告.pdf
"5a88f63fe6bcd7084f9839e83a6b8165|JXHS2000148|JXHS2000148|利伐沙班干混悬剂（JXHS2000148,49）申请上市技术审评报告.pdf"
"fa7564a821b36d8e6fdb91e81aa0ce97|JXHS2000149|JXHS2000149|利伐沙班干混悬剂（JXHS2000148,49）申请上市技术审评报告.pdf"
51da0ea297d8de0a924c62671533f476|CXHS2000030|CXHS2000030|CXHS2000030_盐酸埃克替尼片_上市药品公示附件_审核修订后报告_20220426184629083.pdf
83ec4b7c1bdb1d7f9ff41e78c3b4ce75|JXHS2000147|JXHS2000147|阿替卡因肾上腺素注射液（JXHS2000147）     申请上市技术审评报告.pdf
51bf689128716d41df56e44accaf1464|CXSS2000049|CXSS2000049|猪源纤维蛋白粘合剂（CXSS2000049、50、51）申请上市技术审评报告.pdf
adebea448ac06fadad83b705ae037165|CXSS2000050|CXSS2000050|猪源纤维蛋白粘合剂（CXSS2000049、50、51）申请上市技术审评报告.pdf
8d2106ea6b4de08ab0ec2f7866714695|CXSS2000051|CXSS2000051|猪源纤维蛋白粘合剂（CXSS2000049、50、51）申请上市技术审评报告.pdf
d5e37f20dbe191fdaa2e1543a3d82c0c|JXSS2000032|JXSS2000032|JXSS2000032_阿替利珠单抗注射液_上市药品公示报告.pdf
9fe880638904ffb8246ceb80bbf9f81c|JXSS2000033|JXSS2000033|JXSS2000033_阿替利珠单抗注射液_上市药品公示报告.pdf
01abfd0ec839e7ef72e91ca4a9cfee26|CXHS2000028|CXHS2000028|CXHS2000028_索凡替尼胶囊_上市药品公示报告.pdf
85c4c30783938051b484c75689b9b17c|CXHS2000029|CXHS2000029|艾米替诺福韦片（CXHS2000029）申请上市技术审评报告.pdf
954e6e944afc914006c9dccf379f359b|JXHS2000133|JXHS2000133|碳酸司维拉姆片（JXHS2000133）申请上市技术审评报告.pdf
532cd06ca7b1b5a1f209755a039c103d|CXSS2000047|CXSS2000047|贝伐珠单抗注射液（CXSS2000047）-申请上市技术审评报告.pdf
2ef6edfdb4983ab2fb263763a07313ff|JXHS2000131|JXHS2000131|JXHS2000131_普拉替尼胶囊_上市药品公示报告.pdf
30772c8d2ca59fc8060282bd9e091f7f|CXSS2000046|CXSS2000046|贝伐珠单抗注射液（CXSS2000046）-申请上市技术审评报告.pdf
cb3710dd1625ec38426fdc40c9c40056|CXSS2000045|CXSS2000045|CXSS2000045_注射用卡瑞利珠单抗_上市药品公示报告.pdf
5c5f0ee1bf29c493ecf7ad4086236aac|CXHS2000025|CXHS2000025|无水乙醇注射液（CXHS2000025）申请上市技术审评报告.pdf
8a54aabf6594b4c426f328ca6157d20d|CXHS2000024|CXHS2000024|艾司奥美拉唑镁碳酸氢钠胶囊（CXHS2000024）申请上市技术审评报告.pdf
52d661db20b7ab53424db445d9ba7d4a|CXSS2000044|CXSS2000044|CXSS2000044_注射用纬迪西妥单抗_报告.pdf
bef50285da1659420b2a32fec8fbbeca|JXHS2000128|JXHS2000128|维立西呱片（JXHS2000128-30）申请上市技术审评报告.pdf
a0ae62bd746e06d8c299734c55556f20|CXHS2000023|CXHS2000023|盐酸米托蒽醌脂质体注射液（CXHS2000023）-申请上市技术审评报告.pdf
702ce8e40ed7f43849b8233f26eae684|JXHS2000126|JXHS2000126|利伐沙班片（JXHS2000126-27）申请上市技术审评报告.pdf
05ae8a35e3d65d7c3231e028124a278a|JXHS2000127|JXHS2000127|利伐沙班片（JXHS2000126-27）申请上市技术审评报告.pdf
a5313f50cffb3c2e37420fa58f6b628e|JXHS2000129|JXHS2000129|维立西呱片（JXHS2000128-30）申请上市技术审评报告.pdf
8ec6162578ba0b1d3ef8d3bb40b74440|JXHS2000130|JXHS2000130|维立西呱片（JXHS2000128-30）申请上市技术审评报告.pdf
58ba9501acd1b6e7b103be5ad3765c22|JXHS2000125|JXHS2000125|盐酸决奈达隆片（JXHS2000125）申请上市技术审评报告.pdf
5362b9e3ebe66c1bc0834326eeb87a81|JXHS2000123|JXHS2000123|丁苯那嗪片 （JXHS2000123、124）申请上市技术审评报告.pdf
5b8e1d2e7a76806ce8e6f9c93c3bc308|JXHS2000124|JXHS2000124|丁苯那嗪片 （JXHS2000123、124）申请上市技术审评报告.pdf
9f6cbe88a22fa94effd1e8f3229dd71f|CXSS2000043|CXSS2000043|信迪利单抗注射液（CXSS2000043）申请 上市技术审评报告.pdf
247ec3f7a737a0ed1edf88ecc1622b52|JXHS2000122|JXHS2000122|JXHS2000122.pdf
159565be74be3ec16df1032e7c2e7fa5|CXHS2000022|CXHS2000022|艾诺韦林片（CXHS2000022）申请上市技术审评报告.pdf
a4f07cfe5b44db691b260d9d45b21df6|JXSS2000029|JXSS2000029|度伐利尤单抗注射液 （JXSS2000029、30）申请上市技术审评报告-.pdf
6cebf387ea384a42b566bd404120371f|JXSS2000030|JXSS2000030|度伐利尤单抗注射液 （JXSS2000029、30）申请上市技术审评报告-.pdf
94f291bd3d8785b1abf7ddafbb0cb19d|JXHS2000121|JXHS2000121|瑞派替尼片（JXHS2000121）申请上市技术审评报告.pdf
9d718608f2320b9dd864aab0ae0fb385|CXHS2000021|CXHS2000021|帕米帕利胶囊（CXHS2000021）申请上市技术审评报告.pdf
55d8d996efc326b3793ed4afa9111850|CXHS2000016|CXHS2000016|阿兹夫定片（CXHS2000016-17）申请上市技术审评报告.pdf
b6e0c9566b5bf06f6b741f788c739992|CXHS2000017|CXHS2000017|阿兹夫定片（CXHS2000016-17）申请上市技术审评报告.pdf
256dcb38e36f85063c84d05c6ef93eb6|JXHS2000117|JXHS2000117|拉考沙胺片（JXHS2000117-120）申请上市技术审评报告.pdf
ee58cc21c6af6dc309f6012e4a52657d|JXHS2000118|JXHS2000118|拉考沙胺片（JXHS2000117-120）申请上市技术审评报告.pdf
fe663725b0cb608bb9f0e4989c273185|JXHS2000119|JXHS2000119|拉考沙胺片（JXHS2000117-120）申请上市技术审评报告.pdf
cb07a39db444c4e800d232d23860de6a|JXHS2000120|JXHS2000120|拉考沙胺片（JXHS2000117-120）申请上市技术审评报告.pdf
5fd84a1894f4db8308f1e26bc03f6702|JXSS2000026|JXSS2000026|托珠单抗注射液（皮下注射）（JXSS2000026）申请上市技术审评报告.pdf
09f43145026eedec4b30965d8089c6ec|JXHS2000113|JXHS2000113|二甲双胍维格列汀片(Ⅱ) (JXHS2000113) 二甲双胍维格列汀片(Ⅲ)（JXHS2000114）申请上市技术审评报告.pdf
91b2ab78ef7f77e41d26fc56df6ce534|JXHS2000114|JXHS2000114|二甲双胍维格列汀片(Ⅱ) (JXHS2000113) 二甲双胍维格列汀片(Ⅲ)（JXHS2000114）申请上市技术审评报告.pdf
da95552351475c228537deb2773555e9|JXSS2000021|JXSS2000021|美泊利珠单抗注射液（JXSS2000021）--申请上市技术审评报告.pdf
08f6a544cc434ee070178c4c97cedc05|CXHS2000018|CXHS2000018|海曲泊帕乙醇胺片（CXHS2000018-20）-申请上市技术审评报告.pdf
00fabb2e64ae1beae56c5fb1708addcb|CXHS2000019|CXHS2000019|海曲泊帕乙醇胺片（CXHS2000018-20）-申请上市技术审评报告.pdf
bd20353d68779d429831718756870606|CXHS2000020|CXHS2000020|海曲泊帕乙醇胺片（CXHS2000018-20）-申请上市技术审评报告.pdf
75640f3efd66b05bb0ff676503690319|CXSS2000035|CXSS2000035|CXSS2000035.pdf
e639245bf66e73328edfcb28c2eb9221|CXSS2000039|CXSS2000039|奥木替韦单抗注射液（CXSS2000039）申请上市技术审评报告.pdf
583bef090f65a5a055d631de331aaffc|JXHS2000102|JXHS2000102|JXHS2000102.pdf
9060df9bcc000233949692243dd189db|JXHS2000103|JXHS2000103|askz.pdf
4d61b6fe0eb9ea0bfe06fbaeb356289b|JXHS2000115|JXHS2000115|注射用培美曲塞二钠 （JXHS2000115、116）申请上市技术审评报告.pdf
fe1ca72f96b73c10144bb00c8ad4bb14|JXHS2000116|JXHS2000116|注射用培美曲塞二钠 （JXHS2000115、116）申请上市技术审评报告.pdf
89b05ed7b9f02f7648b19d3e04efa00c|JXSS2000018|JXSS2000018|注射用维布妥昔单抗（JXSS2000018）-申请上市技术审评报告.pdf
40299196aa82769b07c3ed6c93bdf6a9|JXSS2000027|JXSS2000027|阿达木单抗注射液（JXSS2000027）申请上市技术审评报告.pdf
cbec6369820dcdbcbf2c85e727a2ae82|JXSS2000019|JXSS2000019|达雷妥尤单抗注射液（JXSS2000019-20）-申请上市技术审评报告.pdf
dd234cc055245a7713797a4ed0b7d779|JXSS2000020|JXSS2000020|达雷妥尤单抗注射液（JXSS2000019-20）-申请上市技术审评报告.pdf
5e3e697dacac195ab52380fb12dd1c87|CXSS2000036|CXSS2000036|瑞基奥仑赛注射液（CXSS2000036）-申请人上市技术审评报告.pdf
6daab7a9b9b91e6316ad6e475b5685e1|JXHS2000099|JXHS2000099|羧基麦芽糖铁注射液（JXHS2000099-100）申请上市技术审评报告.pdf
0c0d806a1657af623a8ad3a4de8fc11e|JXHS2000100|JXHS2000100|羧基麦芽糖铁注射液（JXHS2000099-100）申请上市技术审评报告.pdf
ec6eb5d61cda987553526b002b5d0af8|CXSS2000033|CXSS2000033|替雷利珠单抗注射液 （CXSS2000033）-申请上市技术审评报告.pdf
02ccd7a44a9ad469c05dc24f57a74d5a|CXSS2000031|CXSS2000031|冻干人用狂犬病疫苗（Vero细胞）（CXSS2000031）-申请上市技术审评报告.pdf
790c06267a4ec06e16aca61c171dfe4f|CXSS2000034|CXSS2000034|赖脯胰岛素注射液（CXSS2000034）申请上市技术审评报告.pdf
9e56e392a1422cff7c739a85105457dc|CXSS2000029|CXSS2000029|贝伐珠单抗注射液（CXSS2000029-30）-申请上市技术审评报告.pdf
c4cddc85babf1b9d83cdb21afba5d2ca|CXSS2000030|CXSS2000030|贝伐珠单抗注射液（CXSS2000029-30）-申请上市技术审评报告.pdf
08e39ab15991a7d8b3a37b5f85ffc83d|CXSS2000032|CXSS2000032|替雷利珠单抗注射液（CXSS2000032）申请 上市技术审评报告.pdf
aa1ebbe9748c0ef960e5c0da14993580|JXHS2000097|JXHS2000097|伊立替康脂质体注射液 （JXHS2000097）报告.pdf
aee8c4c44d6e6d4768ac6eb8ea12ddf1|CXHS2000014|CXHS2000014|海曲泊帕乙醇胺片（CXHS2000014-15）-申请上市技术审评报告.pdf
4aa0c4d171fb9be7efd02a792ab2b9f6|CXHS2000015|CXHS2000015|海曲泊帕乙醇胺片（CXHS2000014-15）-申请上市技术审评报告.pdf
5aeb60ee8da21bf5f38604169889cc6e|CXSS2000027|CXSS2000027|贝伐珠单抗注射液（CXSS2000027）-申请上市技术审评报告.pdf
2fbbd647a535f23a2e3d56199c7d3619|CXSS2000026|CXSS2000026|阿达木单抗注射液（CXSS2000026）申请上市技术审评报告.pdf
a67e07183bda022f46285e62b6fab531|JXHS2000093|JXHS2000093|注射用培美曲塞二钠 （JXHS2000093、94）申请上市技术审评报告.pdf
358468731b94cef88a31cb3ab6b9140c|JXHS2000094|JXHS2000094|注射用培美曲塞二钠 （JXHS2000093、94）申请上市技术审评报告.pdf
60090691ae5a0ee7ec15a2a11aa79035|JXHS2000091|JXHS2000091|沙库巴曲缬沙坦钠片（JXHS2000091-92）申请上市技术审评报告.pdf
1bf2b5b2d76d528643d9ed85e3d13835|JXHS2000092|JXHS2000092|沙库巴曲缬沙坦钠片（JXHS2000091-92）申请上市技术审评报告.pdf
8bfb32851d00ea36f6597ab57d5e12dd|JXHS2000083|JXHS2000083|醋酸艾替班特注射液（JXHS2000083）申请上市技术审评报告.pdf
d8946f7d84d6e7a493e9c39d18e53b4f|JXHS2000074|JXHS2000074|玛巴洛沙韦片（JXHS2000074-75）申请上市技术审评报告.pdf
42ed374a36b3ffe1a93c9c1f767d8b62|JXHS2000075|JXHS2000075|玛巴洛沙韦片（JXHS2000074-75）申请上市技术审评报告.pdf
266eb8d9c4515feeadcdb6a53e362262|CXZS2000001|CXZS2000001|益肾养心安神片（CXZS2000001）申请上市技术审评报告.pdf
f20bf768b8be56db35b2fa02c587fa59|CXHS2000012|CXHS2000012|CXHS2000012-13_赛沃替尼片_上市药品公示报告.pdf
4eebebf74cb755b7d6b26a2b789f1cdc|CXHS2000013|CXHS2000013|CXHS2000012-13_赛沃替尼片_上市药品公示报告.pdf
5c74ecb853a03553d0e9f0822b248e77|CXSS2000022|CXSS2000022|派安普利单抗注射液（CXSS2000022）-申请上市技术审评报告.pdf
5a72fcee9d6764d22c88c34902e8e4a5|JXSS2000016|JXSS2000016|注射用恩美曲妥珠单抗 （JXSS2000016-17）-申请上市技术审评报告.pdf
2a18a2c66d74b4e9bbc5fa3da46e47b6|JXSS2000017|JXSS2000017|注射用恩美曲妥珠单抗 （JXSS2000016-17）-申请上市技术审评报告.pdf
47030b125a5c07a034e04be5cc871d85|JXHS2000057|JXHS2000057|枸橼酸托法替布缓释片（JXHS2000057）申请上市技术审评报告.pdf
c78d1dc9d4475b9d7f95a9d0f14006de|JXHS2000058|JXHS2000058|非诺贝特酸胆碱缓释胶囊（JXHS2000058）申请上市技术审评报告.pdf
0fc0b2c5c9dbef685f93b61bfff009f9|JXHS2000065|JXHS2000065|茚达格莫吸入粉雾剂（JXHS2000065-66）-申请上市技术审评报告.pdf
5a1d06e450ac27c7cf00d17e93a9524a|JXHS2000066|JXHS2000066|茚达格莫吸入粉雾剂（JXHS2000065-66）-申请上市技术审评报告.pdf
883e0bf90246cb53db42f97d7a490163|JXHS2000067|JXHS2000067|茚达特罗糠酸莫米松吸入粉雾剂（JXHS2000067-69）-申请上市技术审评报告.pdf
882356af449a89dccca836c57757e5ee|JXHS2000068|JXHS2000068|茚达特罗糠酸莫米松吸入粉雾剂（JXHS2000067-69）-申请上市技术审评报告.pdf
5fb8b13f634b3b02cc6535e1a7605935|JXHS2000069|JXHS2000069|茚达特罗糠酸莫米松吸入粉雾剂（JXHS2000067-69）-申请上市技术审评报告.pdf
24f963d531284445b86a1a41ab83663f|JXSS2000012|JXSS2000012|艾美赛珠单抗注射液（JXSS2000012-15）-申请上市技术审评报告.pdf
0b9ef23b76f973f5daa08c4dd712ea89|JXSS2000013|JXSS2000013|艾美赛珠单抗注射液（JXSS2000012-15）-申请上市技术审评报告.pdf
95b04d4d602b6ea77e37500faa600391|JXSS2000014|JXSS2000014|艾美赛珠单抗注射液（JXSS2000012-15）-申请上市技术审评报告.pdf
a6b1061d00ab161a3001320217acb0ea|JXSS2000015|JXSS2000015|艾美赛珠单抗注射液（JXSS2000012-15）-申请上市技术审评报告.pdf
00cb80890a986b708e65ac63257ed4c5|CXSS2000018|CXSS2000018|特瑞普利单抗注射液（CXSS2000018-19）公开审评报告 (2).pdf
8eaa0a7b7095cd7fb660138a3e06d2c9|CXSS2000019|CXSS2000019|特瑞普利单抗注射液（CXSS2000018-19）公开审评报告 (2).pdf
2eb218059702a07064081f6b70d4e0cb|CXHS2000010|CXHS2000010|甲苯磺酸多纳非尼片（CXHS2000010）-申请上市技术审评报告.pdf
ff4ffcb98b5ba33d70c2ae21d90c45b9|CXSS2000020|CXSS2000020|注射用英夫利西单抗 （CXSS2000020）.pdf
ee16920e312a78102b711df05eb1cca7|JXSS2000011|JXSS2000011|萨特利珠单抗注射液（JXSS2000011）申请上市技术审评报告.pdf
960755f0fd3b07e31932f163fb0024e1|JXHS2000053|JXHS2000053|盐酸丙卡巴肼胶囊（JXHS2000053）-申请上市技术审评报告.pdf
467e7d49e50643af234d4b5e7981e8bd|CXSS2000016|CXSS2000016|CXSS2000016-17_特瑞普利单抗注射液_上市药品公示报告.pdf
a7a643e772953d12ee27e262ba0f8553|CXSS2000017|CXSS2000017|CXSS2000016-17_特瑞普利单抗注射液_上市药品公示报告.pdf
e7b8c2d59929585ac965217dd5ff61ff|JXHS2000049|JXHS2000049|贝前列素钠缓释片 （JXHS2000049）申请上市技术审评报告.pdf
1b5ddefd56d1483c2668b3ec1e699c69|JXSS2000010|JXSS2000010|帕博利珠单抗注射液（JXSS2000010）-申请上市技术审评报告.pdf
d86a39628f6f04f90bec8b0a05bd0ba0|JXHS2000050|JXHS2000050|阿伐替尼片（JXHS2000050-52）申请上市技术审评报告.pdf
3c957d204ff970ff44ec6222b400f484|JXHS2000051|JXHS2000051|阿伐替尼片（JXHS2000050-52）申请上市技术审评报告.pdf
58c2ab7ca6d1c3960c825908b162caf0|JXHS2000052|JXHS2000052|阿伐替尼片（JXHS2000050-52）申请上市技术审评报告.pdf
f6e5dce111ece2d83acca40582c8229a|CXSS2000015|CXSS2000015|信迪利单抗注射液（CXSS2000015）申请 上市技术审评报告.pdf
10274b5ce0efd5fb3320d882816b8b63|CXSS2000014|CXSS2000014|替雷利珠单抗注射液（CXSS2000014）申请上市技术审评报告.pdf
b191fdd730d0f27bbd560302afc003b3|JXHS2000040|JXHS2000040|富马酸伏诺拉生片（JXHS2000040-41）申请上市技术审评报告.pdf
4bf2b371390dbbbadafb76da3ab4904e|JXHS2000041|JXHS2000041|富马酸伏诺拉生片（JXHS2000040-41）申请上市技术审评报告.pdf
bb4541aae56bc78c3029b372cb64d613|JXHS2000042|JXHS2000042|利司扑兰口服溶液用散（JXHS2000042）申请上市技术审评报告.pdf
55995698da5db36c8532ab4f18021bdc|JXSS2000009|JXSS2000009|地舒单抗注射液 （JXSS2000009）-申请上市技术审评报告.pdf
517c7b3a088c0b132c006629ff3c1cec|CXSS2000013|CXSS2000013|贝伐珠单抗注射液（CXSS2000013）申请上市技术审评报告.pdf
33f679cd3b32f6955bd9d631146aacf1|JXSS2000008|JXSS2000008|注射用罗普司亭（JXSS2000008）- 申请上市技术审评报告.pdf
09054b39f940c9cd839cf21fa38a762c|JXHS2000035|JXHS2000035|瑞舒伐他汀钙片（JXHS2000035-37）申请上市技术审评报告.pdf
1331d53826a15dfff8d0d35ff1bb5bf2|JXHS2000036|JXHS2000036|瑞舒伐他汀钙片（JXHS2000035-37）申请上市技术审评报告.pdf
d73b3e6c418ca65ac3b226c1b4be6e72|JXHS2000037|JXHS2000037|瑞舒伐他汀钙片（JXHS2000035-37）申请上市技术审评报告.pdf
f72e173b7fdeab0a526d11cd731768bb|CXSS2000012|CXSS2000012|贝伐珠单抗注射液（CXSS2000012）申请上市技术审评报告.pdf
7eb71d8a5a6a20c2972b3e9fe6391733|JXHS2000033|JXHS2000033|富马酸吉瑞替尼片JXHS2000033-申请上市技术审评报告.pdf
28ad6c640c44bed5e36640fe3a631d29|JXHS2000032|JXHS2000032|左乙拉西坦注射用浓溶液（JXHS2000032）申请上市技术审评报告.pdf
3005a74a926352b813de298b13c6c2c9|JXSS2000006|JXSS2000006|司美格鲁肽注射液（JXSS2000006-07）申请上市技术审评报告.pdf
95704b721e05cf7cb426573bd230a674|JXSS2000007|JXSS2000007|司美格鲁肽注射液（JXSS2000006-07）申请上市技术审评报告.pdf
3e17875dc3ef9bbd4395c53fc9dd121f|JXHS2000031|JXHS2000031|枸橼酸钠血滤置换液（JXHS2000031）申请上市技术审评报告.pdf
80447335274ebafd86a068f462d0134e|CXSS2000008|CXSS2000008|四价流感病毒裂解疫苗（CXSS2000008）-申请上市技术审评报告.pdf
35a0db0db87a822c4e885c4504540125|JXSS2000003|JXSS2000003|注射用贝利尤单抗（JXSS2000003-4）申请上市技术审评报告.pdf
352fba095b785ecf8bc83989c15c5422|JXSS2000004|JXSS2000004|注射用贝利尤单抗（JXSS2000003-4）申请上市技术审评报告.pdf
65ae1ce20432f98daf3d4da8b7535a00|CXHS2000009|CXHS2000009|甲苯磺酸尼拉帕利胶囊（CXHS2000009）申请上市技术审评报告.pdf
91aa15bf802351b7983da9fced246931|CXSS2000009|CXSS2000009|甘精胰岛素注射液（CXSS2000009）申请上市技术审评报告.pdf
4b0aa10551631fc089fdd9ee6111d528|JXHS2000024|JXHS2000024|氯吡格雷阿司匹林片（JXHS2000024）申请上市技术审评报告.pdf
a2f978e85ba532001f83bca6d34d80ac|JXHS2000027|JXHS2000027|达格列净片（JXHS2000027-28）申请上市技术审评报告.pdf
9cce0d99f805200368fafc9e74203fb5|JXHS2000028|JXHS2000028|达格列净片（JXHS2000027-28）申请上市技术审评报告.pdf
1c5c3d82dad48b21bc837a19e9a3074d|CXHS2000008|CXHS2000008|奥布替尼片 CXHS2000008-申请上市技术审评报告.pdf
baeb47e066a80f2499aa6f660d0f1a10|JXHS2000021|JXHS2000021|注射用亚锡替曲膦(JXHS2000021)  申请上市技术审评报告.pdf
1c573b10ea46a790a97e157bfaffd262|JXHS2000020|JXHS2000020|普乐沙福注射液（JXHS2000020)申请上市技术审评报告.pdf
a6e2403bb6315c044e12a6fbf1a2d67a|CXSS2000006|CXSS2000006|阿基仑赛注射液（CXSS2000006）-申请上市技术审评报告.pdf
ad2cc051dbaba670f0edcfd41d2dde8a|CXSS2000005|CXSS2000005|赛帕利单抗注射液（CXSS2000005）-申请上市技术审评报告.pdf
a45c532a63cc0f25dc738e00042918fd|CXHS2000004|CXHS2000004|甲磺酸阿帕替尼片（CXHS2000004）-申请上市技术审评报告.pdf
1aa3ab6edbc2a7eb7c23207b9063957b|JXHS2000016|JXHS2000016|盐酸头孢卡品酯颗粒 （JXHS2000016）报告.pdf
d5fbb5ce21d6727370ed0656d9d67120|JXHS2000007|JXHS2000007|达罗他胺片薄膜衣片（JXHS2000007-0）公开审评报告 公示版.pdf
30f503e7bbcb8925d1fdc4cbdded62c3|JXHS2000013|JXHS2000013|富马酸二甲酯肠溶胶囊（JXHS2000013-14）申请上市技术审评报告.pdf
db3e68a0cac7114cef46deae2ccb95a6|JXHS2000014|JXHS2000014|富马酸二甲酯肠溶胶囊（JXHS2000013-14）申请上市技术审评报告.pdf
ff3b24ef708f8d20800820985979b537|JXSS2000002|JXSS2000002|阿替利珠单抗注射液（JXSS2000002）-申请上市技术审评报告.pdf
2f412c48396dcce898a7050817a6ba22|CXHS2000002|CXHS2000002|CXHS2000003.pdf
b7a79dd5dd9551fd9f15a54bceefbf55|CXHS2000003|CXHS2000003|CXHS2000003.pdf
839ee716ae8ca17aebad6011e6eaa89a|CXSS2000004|CXSS2000004|注射用英夫利西单抗（CXSS2000004）申请上市技术审评报告.pdf
827cb584e8a53b1f4f4dcf7c305dfab9|JXHS2000008|JXHS2000008|JXHS2000008.pdf
a4c8b906a6de75d3ebbf12c3bdb5dde4|CXSS2000003|CXSS2000003|肠道病毒71型灭活疫苗（Vero细胞） （CXSS2000003）-申请上市技术审评报告.pdf
1e4ce94f54719bb758fa2f4bef3ca902|CXHS2000001|CXHS2000001|环泊酚注射液（CXHS2000001） 申请上市技术审评报告.pdf
aee40373e3833e2c7f4ced62443d6181|JXSS2000001|JXSS2000001|注射用伊珠单抗奥唑米星（JXSS2000001）-申请上市技术审评报告.pdf
f0bdd32fe6e9fccd2b08e945777726ec|JXHS1900191|JXHS1900191|拉莫三嗪分散片（JXHS1900191-194）-申请上市技术审评报告.pdf
7f4094bba1e4186dc4203e252e897392|JXHS1900192|JXHS1900192|拉莫三嗪分散片（JXHS1900191-194）-申请上市技术审评报告.pdf
f426b256779832173e4dbc31654f0500|JXHS1900193|JXHS1900193|拉莫三嗪分散片（JXHS1900191-194）-申请上市技术审评报告.pdf
8bdfef8e9d2e4370010cb1e4d1d60671|JXHS1900194|JXHS1900194|拉莫三嗪分散片（JXHS1900191-194）-申请上市技术审评报告.pdf
2c992aa9a592ea69d58e487ed29e7457|JXHS2000002|JXHS2000002|维奈克拉片（JXHS2000002）-申请上市技术审评报告.pdf
801ec77fa21a8e964d5fdad9e0414024|JXHS2000003|JXHS2000003|维奈克拉片（JXHS2000002）-申请上市技术审评报告.pdf
c12b625547ac12c3558923586040b239|JXHS2000004|JXHS2000004|维奈克拉片（JXHS2000002）-申请上市技术审评报告.pdf
c387be6c0f35684059f7dfca7e610e56|JXHS2000001|JXHS2000001|吸入用一氧化氮（JXHS2000001）     申请上市技术审评报告.pdf
1330105171902144cb420892ec84ab42|JXHS1900173|JXHS1900173|布地奈德福莫特罗吸入粉雾剂(II)（JXHS1900173-174）申请上市技术审评报告.pdf
75535627bf90921579cbef47aa3b2fe7|JXHS1900174|JXHS1900174|布地奈德福莫特罗吸入粉雾剂(II)（JXHS1900173-174）申请上市技术审评报告.pdf
68e8c1b73b7b0a8c31a4ecb68e31e934|JXHS1900189|JXHS1900189|利鲁唑口服混悬液 （JXHS1900189）申请上市技术审评报告.pdf
31da997e86b3c1f55e5972e43d130422|CXHS1900044|CXHS1900044|康替唑胺片 （CXHS1900044）申请上市技术审评报告.pdf
e9f537195d76d4d3d17a33ef5e80b8e4|JXHS1900175|JXHS1900175|氘代丁苯那嗪片（JXHS1900175-180）申请上市技术审评报告.pdf
94545e2a937185b4b12150cff24e5f33|JXHS1900176|JXHS1900176|氘代丁苯那嗪片（JXHS1900175-180）申请上市技术审评报告.pdf
a6819ac660ae398b825b1013aa4f68f3|JXHS1900177|JXHS1900177|氘代丁苯那嗪片（JXHS1900175-180）申请上市技术审评报告.pdf
ccf196e1fcc8d7db67f6718097c59630|JXHS1900178|JXHS1900178|氘代丁苯那嗪片（JXHS1900175-180）申请上市技术审评报告.pdf
d50ede50ce11105de0b5f63dd062bf1a|JXHS1900179|JXHS1900179|氘代丁苯那嗪片（JXHS1900175-180）申请上市技术审评报告.pdf
ef6cf0be70d4a3ce7af6263554ee4a78|JXHS1900180|JXHS1900180|氘代丁苯那嗪片（JXHS1900175-180）申请上市技术审评报告.pdf
bbb145017fcf7a2bc22ac896a560cdfa|JXSS1900067|JXSS1900067|JXSS1900067.pdf
46383b5f777906e2e336cf6b28dd1d8f|CXHS1900043|CXHS1900043|示踪用盐酸米托蒽醌注射液(CXHS1900043)申请上市技术审评报告.pdf
8778f3ccfe1b6ed13f5a58d662157b0d|JXHS1900169|JXHS1900169|乙磺酸尼达尼布软胶囊（JXHS1900169-170）申请上市技术审评报告.pdf
594ccb3d4eb2cc7e00e8fecf6a5d3052|JXHS1900170|JXHS1900170|乙磺酸尼达尼布软胶囊（JXHS1900169-170）申请上市技术审评报告.pdf
583a50659a9651e914a068b845b34d59|JXHS1900168|JXHS1900168|恩曲他滨替诺福韦片（JXHS1900168）申请上市技术审评报告.pdf
0ba244238af99b4f4ab65a709e6d56c3|CXHS1900040|CXHS1900040|CXHS1900040-42_盐酸安罗替尼胶囊_上市药品公示报告.pdf
1f823fceeb386389432d22162290e61e|CXHS1900041|CXHS1900041|CXHS1900040-42_盐酸安罗替尼胶囊_上市药品公示报告.pdf
dd83c42944483bf786ff4c3b2560907c|CXHS1900042|CXHS1900042|CXHS1900040-42_盐酸安罗替尼胶囊_上市药品公示报告.pdf
6d55c90a6ac1176bcb9435428fed496a|CXSS1900046|CXSS1900046|13价肺炎球菌多糖结合疫苗（破伤风类毒素白喉类毒素）（CXSS1900046）-申请上市技术审评报告.pdf
8c34a0e28cb83d71f47a0287e13df808|CXHS1900039|CXHS1900039|CXHS1900039_甲磺酸艾氟替尼片_报告_.pdf
ed2caa7df4f26f6d457d36bbb9ab84a2|JXHS1900155|JXHS1900155|利格列汀片（JXHS1900155）--申请上市技术审评报告.pdf
c8192922be114ff06864e7e69ff39dd9|JXHS1900157|JXHS1900157|甲磺酸仑伐替尼胶囊（JXHS1900157-158）-申请上市技术审评报告.pdf
3cb2d2a5e603138a8a0ffbbbae596a8f|JXHS1900158|JXHS1900158|甲磺酸仑伐替尼胶囊（JXHS1900157-158）-申请上市技术审评报告.pdf
604f0904f9c1d06fef6738580832b655|JXHS1900163|JXHS1900163|恩扎卢胺软胶囊（JXHS1900163）-申请上市技术审评报告.pdf
0552029cfbfe1636aba5310dcd92d5db|JXHS1900156|JXHS1900156|阿帕他胺片（JXHS1900156）-申请上市技术审评报告.pdf
5ecbdc2e9f12fd4c4672eef931e68b60|JXHS1900151|JXHS1900151|来那度胺胶囊（JXHS1900151-54）-申请上市技术审评报告.pdf
4fc206d4de9d718f58b28f7ff099abe5|JXHS1900152|JXHS1900152|来那度胺胶囊（JXHS1900151-54）-申请上市技术审评报告.pdf
777de06430d3cf6e91f0433efa52425c|JXHS1900153|JXHS1900153|来那度胺胶囊（JXHS1900151-54）-申请上市技术审评报告.pdf
47349e90775847d2fc6b19af737b7183|JXHS1900154|JXHS1900154|来那度胺胶囊（JXHS1900151-54）-申请上市技术审评报告.pdf
c041d77f010ad437c91832ccb8c100b6|JXHS1900150|JXHS1900150|注射用卡非佐米（JXHS1900150）-申请上市技术审评报告.pdf
caec428bc0f23015129fcacad1c0d5a7|CXHS1900036|CXHS1900036|注射用利培酮微球（Ⅱ）（CXHS1900036-38）申请上市技术审评报告.pdf
b4b05b9ad2b5fac5c780a34fe9a6a29c|CXHS1900037|CXHS1900037|注射用利培酮微球（Ⅱ）（CXHS1900036-38）申请上市技术审评报告.pdf
5fdfc6ead47006e882acf7b655304949|CXHS1900038|CXHS1900038|注射用利培酮微球（Ⅱ）（CXHS1900036-38）申请上市技术审评报告.pdf
388640194a9c4843bc0470b917fd2962|JXSS1900062|JXSS1900062|注射用重组人凝血因子IX -Fc融合蛋白（JXSS1900062）-申请上市技术审评报告.pdf
3fd2749a137df7af959cbfeeaf697072|JXSS1900063|JXSS1900063|注射用重组人凝血因子IX -Fc融合蛋白（JXSS1900063）-申请上市技术审评报告.pdf
080a75f99e518c191e56d42f32747805|JXSS1900064|JXSS1900064|注射用重组人凝血因子IX -Fc融合蛋白（JXSS1900064）-申请上市技术审评报告.pdf
61d418a304dbfe3fd9f75d9765ee3046|JXSS1900065|JXSS1900065|注射用重组人凝血因子IX -Fc融合蛋白（JXSS1900065）-申请上市技术审评报告.pdf
1188367173f5be7c79aaf7794e001d51|JXHS1900147|JXHS1900147|拉米夫定多替拉韦片（JXHS1900147）申请上市技术审评报告.pdf
07074c47d9784db25878a473029064c2|CXHS1900035|CXHS1900035|奥布替尼片 CXHS1900035-申请上市技术审评报告.pdf
a631de382ec948192e417cf124577571|CXSS1900042|CXSS1900042|注射用重组人凝血因子VIII（CXSS1900042）-申请上市技术审评报告.pdf
b61413da3fbfc61b3f919471cb3b615c|CXSS1900043|CXSS1900043|注射用重组人凝血因子VIII（CXSS1900043）-申请上市技术审评报告.pdf
f4c12b2cc31322b92cdb317acc94d8d5|JXHS1900144|JXHS1900144|阿贝西利片（JXHS1900144-146）-申请上市技术审评报告.pdf
3a88a6e4e0f32b7ade6f3f5b5ca1a83f|JXHS1900145|JXHS1900145|阿贝西利片（JXHS1900144-146）-申请上市技术审评报告.pdf
00aaf94427b4f91032f760788046e7ea|JXHS1900146|JXHS1900146|阿贝西利片（JXHS1900144-146）-申请上市技术审评报告.pdf
8d3574613859fe422bda252164390e8b|CXHS1900034|CXHS1900034|索凡替尼胶囊（CXHS1900034）-申请上市技术审评报告.pdf
2cbc79184deda24baf2d5f82b66d7813|CXSS1900040|CXSS1900040|注射用泰它西普（CXSS1900040）申请上市技术审评报告.pdf
fadbf7cfca58ce820a621d0943c5b9e2|CXSS1900041|CXSS1900041|阿达木单抗注射液（CXSS1900041） 申请上市技术审评报告.pdf
527eec59080d7a7788319a05963a0db1|JXSS1900061|JXSS1900061|注射用A型肉毒毒素（JXSS1900061）申请上市技术审评报告.pdf
d19b03602d6ffb031852e3ccb51166c2|CXSS1900038|CXSS1900038|CXSS1900038_门冬胰岛素注射液_报告.pdf
33e675d7e6e5ac1df7e17bec23b9b7a3|JXHS1900130|JXHS1900130|磷碳酸氢钠血滤置换液（JXHS1900130）申请上市技术审评报告.pdf
4daddebfff1b252b960d6f116bf2efa4|CXHS1900033|CXHS1900033|氟唑帕利胶囊（CXHS1900033）-申请上市技术审评报告.pdf
29657daf4b24cc8efadb95bd68e2465f|JXHS1900126|JXHS1900126|盐酸帕洛诺司琼注射液（JXHS1900126)-申请上市技术审评报告.pdf
ce6518b0e4636b097ce86fa34d22f1e8|JXSS1900060|JXSS1900060|注射用贝林妥欧单抗（JXSS1900060）-申请上市技术审评报告.pdf
a4478dad0347e6a6d24d784e87520bd7|JXHS1900122|JXHS1900122|左西孟旦注射液（JXHS1900122）申报上市注册申请技术审评报告.pdf
b78a341a003c9652b633f5ba21218a1a|JXHS1900113|JXHS1900113|多种微量元素注射液（Ⅲ）（JXHS1900113）申请上市技术审评报告.pdf
8480d400f4971972d8ee77ecb88fd72c|JXHS1900116|JXHS1900116|氢溴酸替格列汀片（JXHS1900116） 申请上市技术审评报告.pdf
b726a1de62912d3da1ba7722430040d9|JXHS1900117|JXHS1900117|氯苯唑酸软胶囊（JXHS1900117）申请上市技术审评报告.pdf
674e0abb1eac42a99c11134db1563bdd|JXHS1900119|JXHS1900119|碳酸氢钠血滤置换液（JXHS1900119）申请上市技术审评报告.pdf
d0e8c2c04b2a1b1be44a5e203a73aa56|JXSS1900059|JXSS1900059|奥妥珠单抗注射液 （JXSS1900059）-申请上市技术审评报告.pdf
c40d86b6d1f899de085467c4db7d052d|JXHS1900114|JXHS1900114|多拉韦林片（JXHS1900114）申请上市技术审评报告.pdf
3e3200543461849343531e3e164c31b4|JXHS1900115|JXHS1900115|多拉米替片（JXHS1900115）申请上市技术审评报告.pdf
fa19549618ef6178b5ef17b4fbe90d86|JXHS1900111|JXHS1900111|他克莫司颗粒（JXHS1900111-112）申报上市注册申请技术审评报告.pdf
10c8a3ea9c7e7b500fc8f257c38ca08a|JXHS1900112|JXHS1900112|他克莫司颗粒（JXHS1900111-112）申报上市注册申请技术审评报告.pdf
dbd914545ab4bb2288acd76004088b53|JXHS1900118|JXHS1900118|枸橼酸西地那非片（JXHS1900118）申请上市技术审评报告.pdf
834d6d68e1fd08000aa9d0f4f0d9e444|CXHS1900032|CXHS1900032|西格列他钠片（CXHS1900032)申请上市技术审评报告.pdf
803109c7ca83cbe81c469c60233aa855|CXHS1900028|CXHS1900028|奥氮平口溶膜（CXHS1900028-29）-申请上市技术审评报告.pdf
453a918a3c254c7ec880c99fe57e9a69|CXHS1900029|CXHS1900029|奥氮平口溶膜（CXHS1900028-29）-申请上市技术审评报告.pdf
e45889c7550f6f0d2868e140574412e1|CXZS1900002|CXZS1900002|连花清咳片（CXZS1900002）申请上市技术审评报告.pdf
dfb14cabea4eb41c07b7917310f23321|CXHS1900030|CXHS1900030|磷酸依米他韦胶囊（CXHS1900030）申请上市技术审评报告.pdf
a4c07f8ce00f338570e45f96e8ea0534|CXSS1900034|CXSS1900034|注射用卡瑞利珠单抗（CXSS1900034）申请上市技术审评报告.pdf
f46beb7b35632da34b1c18b35ed5e7fc|CXSS1900035|CXSS1900035|注射用卡瑞利珠单抗（CXSS1900035）申请上市技术审评报告.pdf
5b5e6b8b9391a25263a51c72d7725b78|CXHS1900024|CXHS1900024|普瑞巴林缓释片（CXHS1900024-26）申请上市技术审评报告.pdf
b4209d8fc97107673faec5c9321bca79|CXHS1900025|CXHS1900025|普瑞巴林缓释片（CXHS1900024-26）申请上市技术审评报告.pdf
8638dfb96858ef98081204b669c40442|CXHS1900026|CXHS1900026|普瑞巴林缓释片（CXHS1900024-26）申请上市技术审评报告.pdf
d414c15ff20ba6f744d653fd012a1601|JXSS1900056|JXSS1900056|布罗索尤单抗注射液（JXSS1900056-58）申请上市技术审评报告.pdf
51a200f7ea42c07d6e98b71cfad550cd|JXSS1900057|JXSS1900057|布罗索尤单抗注射液（JXSS1900056-58）申请上市技术审评报告.pdf
a8b74054f7918b7b12fd6184069df608|JXSS1900058|JXSS1900058|布罗索尤单抗注射液（JXSS1900056-58）申请上市技术审评报告.pdf
caecffbfe92421b7bd64532a1c873c5b|JXHS1900109|JXHS1900109|氯化镭[223Ra]注射液（JXHS1900109）申请上市技术审评报告.pdf
f2e48aa2694944f3a7c85d6052ba0921|JXSS1900051|JXSS1900051|注射用重组人凝血因子VIII（JXSS1900051）-申请上市技术审评报告.pdf
d93c6141136f938af161eda4f05ced12|JXSS1900053|JXSS1900053|JXSS1900053.pdf
8312d5f49a69ec3c98ece44d77a38600|JXSS1900054|JXSS1900054|JXSS1900054.pdf
e1bd06b08f945ccf2b2629cf4a0c6719|JXSS1900055|JXSS1900055|JXSS1900054.pdf
56f463321f78a19338548d04fff96966|CXHS1900023|CXHS1900023|兰索拉唑碳酸氢钠胶囊（CXHS1900023）申请上市技术审评报告.pdf
5ab3e10b36a65a0f132bb9e920f12c80|JXHS1900106|JXHS1900106|泊沙康唑注射液（JXHS1900106）申请上市技术审评报告.pdf
75f90495160a6cb505c962ac1c5a754f|JXSS1900052|JXSS1900052|注射用重组人凝血因子VIII（JXSS1900052）-申请上市技术审评报告.pdf
5c325aec0a2792a5d49c4cb91cab682d|CXHS1900022|CXHS1900022|注射用磷酸左奥硝唑酯二钠（CXHS1900022）申请上市技术审评报告.pdf
55af8649627654225b14bba55381828e|JXHS1900105|JXHS1900105|盐酸利多卡因粉末无针注射皮内给药系统（JXHS1900105）     申请上市技术审评报告.pdf
d8c80f8b1c04df67f3dfc44e781464b8|JXSS1900046|JXSS1900046|艾度硫酸酯酶β注射液（JXSS1900046）-申请上市技术审评报告.pdf
bb0dd7b4e13e1e65dc9e41d49bb6b6d6|CXHS1900020|CXHS1900020|环泊酚注射液（CXHS1900020）申请上市技术审评报告.pdf
4d6bcbd4ee0fc143a1670e11d26f1377|JXSS1900044|JXSS1900044|帕博利珠单抗注射液（JXSS1900044）申请上市技术审评报告.pdf
a49f465678d38ed9fa604f5aefb25653|JXHS1900100|JXHS1900100|氯苯唑酸葡胺软胶囊（JXHS1900100）申请上市技术审评报告.pdf
2b8b242b97e5be01da438de34328929f|CXHS1900018|CXHS1900018|注射用紫杉醇聚合物胶束（CXHS1900018）_报告_.pdf
0014e7418386c75b72223a8947789eaa|CXHS1900016|CXHS1900016|孟鲁司特钠口溶膜（CXHS1900016-17）-申请上市技术审评报告.pdf
45e2d89ef42dea22afbde6491676ce4d|CXHS1900017|CXHS1900017|孟鲁司特钠口溶膜（CXHS1900016-17）-申请上市技术审评报告.pdf
7af7a09f5dd44cf34c704758020f0019|JXHS1900089|JXHS1900089|蒙脱石混悬液（JXHS1900089）申请上市技术审评报告.pdf
f0329a1de7a08a40362f5bea3f61dcdc|JXHS1900090|JXHS1900090|曲美替尼片（JXHS1900090-91）申请上市技术审评报告.pdf
415368e9189ac03047563fb05fcb521a|JXHS1900091|JXHS1900091|曲美替尼片（JXHS1900090-91）申请上市技术审评报告.pdf
492754eae4028558bb350b04c496c352|JXHS1900092|JXHS1900092|甲磺酸达拉非尼胶囊（JXHS1900092-93）申请上市技术审评报告.pdf
d1a45ad914d0a247f33c14d6778abda1|JXHS1900093|JXHS1900093|甲磺酸达拉非尼胶囊（JXHS1900092-93）申请上市技术审评报告.pdf
af1e1ad5d226547cb8f756e05c19a27f|JXHS1900086|JXHS1900086|乙磺酸尼达尼布软胶囊（JXHS1900086、88）申请上市技术审评报告.pdf
c9ea2b4d4c6a286e00aae49f2b1ba7d9|JXHS1900088|JXHS1900088|乙磺酸尼达尼布软胶囊（JXHS1900086、88）申请上市技术审评报告.pdf
5a43cfcc4b33f55033e29ee7b2d6561d|JXHS1900098|JXHS1900098|环硅酸锆钠散（JXHS1900098-99）申请上市技术审评报告.pdf
4cb7f64d8c74d76bf64510840a481bea|JXHS1900099|JXHS1900099|环硅酸锆钠散（JXHS1900098-99）申请上市技术审评报告.pdf
04f91f2c365ca129a38b4864d9b458d8|CXSS1900029|CXSS1900029|人凝血酶原复合物（CXSS1900029）-申请上市技术审评报告.pdf
caec57088944101d4f7b9e74c9f1cfdb|CXSS1900031|CXSS1900031|聚乙二醇化重组人粒细胞刺激因子注射液（CXSS1900031）-申请上市技术审评报告.pdf
957f26d7ee1106f6ebb4d7fe9be8953d|JXSS1900037|JXSS1900037|纳武利尤单抗注射液（JXSS1900037-38）申请上市技术审评报告.pdf
24384b7e1c01a9acd32bb6480390b244|JXSS1900038|JXSS1900038|纳武利尤单抗注射液（JXSS1900037-38）申请上市技术审评报告.pdf
7c1d2f9a854ce45e6574bdf289225328|CXSS1900030|CXSS1900030|利妥昔单抗注射液（CXSS1900030）申请上市技术审评报告.pdf
12011cf1c15777374b001a9f36e51aa6|JXSS1900036|JXSS1900036|注射用A型肉毒毒素（受理号：JXSS1900036）申请上市技术审评报告.pdf
da8e8b5d3cd09394d8e7b001f84de762|JXHS1900080|JXHS1900080|富马酸卢帕他定片（JXHS1900080）申请上市技术审评报告.pdf
e41834025d1b1a1745b275499a513dda|JXSS1900034|JXSS1900034|地舒单抗注射液（JXSS1900034）申请上市技术审评报告.pdf
020587439b2a5dde4d098a8f3498521a|JXSS1900035|JXSS1900035|JXSS1900035.pdf
8e58d6c2099304df8e976581c829b652|CXHS1900014|CXHS1900014|水合氯醛糖浆组合包装（CXHS1900014-15）申请上市技术审评报告.pdf
319e9f217b91efc8ff631d5f96eca50d|CXHS1900015|CXHS1900015|水合氯醛糖浆组合包装（CXHS1900014-0）申请上市技术审评报告.pdf
92eedb736d193c43e3badaffa264417c|JXSS1900031|JXSS1900031|JXSS1900031.pdf
9dfd95cdde4844d42ee354c44881560d|JXSS1900032|JXSS1900032|注射用维得利珠单抗（JXSS1900032-33）申请上市技术审评报告.pdf
dd5f4c8e92704c37b1d7336f6914d32c|JXSS1900033|JXSS1900033|注射用维得利珠单抗（JXSS1900032-33）申请上市技术审评报告.pdf
01eda6a9d0b6747e41c8bb416e35418d|JXHS1900078|JXHS1900078|索磷维伏片（JXHS1900078）申请上市技术审评报告.pdf
54149666ecf9a8856275ee92a4756503|JXSS1900030|JXSS1900030|甘精胰岛素注射液 （JXSS1900030）-申请上市技术审评报告.pdf
8be36b2cebc79666a29cad9bba1cf644|CXHS1900013|CXHS1900013|注射用甲苯磺酸瑞马唑仑（CXHS1900013）申请上市技术审评报告.pdf
c62d284b85fd0d2e56dd48e505d1e0a0|JXSS1900029|JXSS1900029|注射用拉罗尼酶浓溶液(JXSS1900029)申请上市技术审评报告.pdf
a3584b441415fc6b58f47ef4b0e8d1cc|CXHS1900012|CXHS1900012|左奥硝唑分散片（CXHS1900012）申请上市技术审评报告.pdf
9a1ae3ee2a8905a0dca0778af4175306|CXSS1900025|CXSS1900025|替雷利珠单抗注射液   ( CXSS1900025) 申请上市技术审评报告.pdf
dee2e4404ab3ee1b6b2f4735f371db85|JXHS1900062|JXHS1900062|盐酸非索非那定片（JXHS1900062-64）-申请上市技术审评报告.pdf
8f5b56f5690f91720302fd25425434b2|JXHS1900063|JXHS1900063|盐酸非索非那定片（JXHS1900062-64）-申请上市技术审评报告.pdf
737dab48bbf9cc6530f9fc2c2e96edbe|JXHS1900064|JXHS1900064|盐酸非索非那定片（JXHS1900062-64）-申请上市技术审评报告.pdf
b4a9c127f75709267f0eb180ef6fba12|JXHS1900067|JXHS1900067|替格瑞洛分散片（JXHS1900067）申请上市技术审评报告.pdf
6955d635416bd9cded43010ad421cbc5|JXSS1900025|JXSS1900025|司库奇尤单抗注射液（JXSS1900025）申请上市技术审评报告.pdf
164e1181580eca51326f5341cbaf19bc|CXSS1900023|CXSS1900023|注射用卡瑞利珠单抗（CXSS1900023）申请上市技术审评报告.pdf
3b0078620acf7615979016b8fd759c9d|JXSS1900024|JXSS1900024|贝伐珠单抗注射液（JXSS1900024）申请上市技术审评报告.pdf
c95b8a5b0b250d3efb0cb21b43dfbf36|CXSS1900022|CXSS1900022|人凝血酶原复合物（CXSS1900022）-申请上市技术审评报告.pdf
f9cef4d3f60e622b6423073137e36910|JXSS1900020|JXSS1900020|JXSS1900020_利妥昔单抗注射液报告.pdf
b3ef4bbcca09e47baf5b6b78e80b2cb9|JXSS1900022|JXSS1900022|JXSS1900020-23_利妥昔单抗注射液报告.pdf
4383ae85baf8cefaebc3f293d006e1e8|CXSS1900021|CXSS1900021|注射用曲妥珠单抗 （CXSS1900021）申请上市技术审评报告.pdf
a1e6947e00daf24a6a2f137784325586|JXSS1900015|JXSS1900015|注射用维布妥昔单抗（JXSS1900015）申请上市技术审评报告.pdf
6948789edf11e244115e00444eeaaca2|JXSS1900016|JXSS1900016|JXSS1900016_利妥昔单抗注射液报告.pdf
3dd76c0fac459faa136204c2405f751a|JXSS1900018|JXSS1900018|JXSS1900016-19_利妥昔单抗注射液报告.pdf
22f41b6117391ef3e9468c0516e0a751|JXSS1900021|JXSS1900021|JXSS1900020-23_利妥昔单抗注射液报告.pdf
fe808c7fe25dabdea1dfcd168ca29023|JXSS1900023|JXSS1900023|JXSS1900020-23_利妥昔单抗注射液报告.pdf
313a3fc2340d33d12567f16da361dd26|CXSS1900020|CXSS1900020|黄花蒿花粉变应原舌下滴剂（CXSS1900020）-申请上市技术审评报告.pdf
7b6bf5ed82de59f93e8cc2babf0f2eb3|JXSS1900017|JXSS1900017|JXSS1900016-19_利妥昔单抗注射液报告.pdf
72828607fb799c875395045cc946dc48|JXSS1900019|JXSS1900019|JXSS1900016-19_利妥昔单抗注射液报告.pdf
c74c364feb7fdb5f8e0161763144a9a2|CXHS1900009|CXHS1900009|左奥硝唑胶囊（CXHS1900009）申请上市技术审评报告.pdf
9951f324269836ace30c29c5046527bb|CXHS1900011|CXHS1900011|甲磺酸阿美替尼片(CXHS1900011)申请上市技术审评报告.pdf
34fedf9864e314992bcea22040eab7fc|CXSS1900018|CXSS1900018|门冬胰岛素注射液(CXSS1900018-019)申请上市技术审评报告.pdf
a6d99b9669c12f2906f7e77d6f78fc80|CXSS1900019|CXSS1900019|门冬胰岛素注射液(CXSS1900018-019)申请上市技术审评报告.pdf
6826983338dcb64b180bb4ce565fd55c|JXSS1900014|JXSS1900014|西妥昔单抗注射液 ( JXSS1900014）-申请上市技术审评报告.pdf
cc44743186dd3997667d2d7807c234d9|JXHS1900047|JXHS1900047|依达拉奉氯化钠注射液（JXHS1900047）申请上市技术审评报告.pdf
a6dec5794e6f958ef22cf7946d8b112c|CXSS1900017|CXSS1900017|猪源纤维蛋白粘合剂（CXSS1900017）申请上市技术审评报告.pdf
4189823e99c42a2d9511dfa182518a6a|JXHS1900046|JXHS1900046|盐酸芬戈莫德胶囊（JXHS1900046）申请上市技术审评报告.pdf
9263a4a5d597ec69fc2060a4b0138585|JXHS1900045|JXHS1900045|阿伐曲泊帕片（JXHS1900045）申请上市技术审评报告.pdf
f87653875bc8f53305ce163a82b794f9|CXZS1900001|CXZS1900001|筋骨止痛凝胶(CXZS1900001）申请上市技术审评报告.pdf
6c98988e11856c4da38154bcb3710700|CXSS1900016|CXSS1900016|四价流感病毒裂解疫苗（CXSS1900016）-申请上市技术审评报告.pdf
5b9378ebc9401abb58da3a7e8cf36ce5|JXSS1900011|JXSS1900011|拉那利尤单抗注射液（JXSS1900011）申请上市技术审评报告.pdf
847a86b801be88bc7407ac08ae5d9d39|JXSS1900012|JXSS1900012|注射用恩美曲妥珠单抗  (JXSS1900012-13）申请上市技术审评报告.pdf
0240b31cfbee6f56d7f735cd4b481e8a|JXSS1900013|JXSS1900013|注射用恩美曲妥珠单抗  (JXSS1900012-13）申请上市技术审评报告.pdf
9b0a7ad17635121c60dc3ea5376754be|JXHS1900036|JXHS1900036|阿帕他胺片（JXHS1900036）申请上市技术审评报告.pdf
b4b1cd10b41fc21c45fdb87e383f600d|CXSS1900009|CXSS1900009|注射用重组人生长激素（CXSS1900009-014）申请上市技术审评报告.pdf
2f6b2b4b8457467f680b4d6eaaf6cf48|CXSS1900010|CXSS1900010|注射用重组人生长激素（CXSS1900009-014）申请上市技术审评报告.pdf
d735f59f306e59ed09a791427b98a8e6|CXSS1900011|CXSS1900011|注射用重组人生长激素（CXSS1900009-014）申请上市技术审评报告.pdf
965b0be60e575000cb1c2d70a9cd3b9a|CXSS1900012|CXSS1900012|注射用重组人生长激素（CXSS1900009-014）申请上市技术审评报告.pdf
cad6b885358c461817ef92696f835724|CXSS1900013|CXSS1900013|注射用重组人生长激素（CXSS1900009-014）申请上市技术审评报告.pdf
8d81c458b495b62d5fef0fd444c58acd|CXSS1900014|CXSS1900014|注射用重组人生长激素（CXSS1900009-014）申请上市技术审评报告.pdf
86eee98063a69985e15d94f00ca9ed10|CXHS1900007|CXHS1900007|注射用左亚叶酸（CXHS1900007-8）申请上市技术审评报告.pdf
d02a4786b4ccb600d7dae858a8144c28|CXHS1900008|CXHS1900008|注射用左亚叶酸（CXHS1900007-8）申请上市技术审评报告.pdf
5b7d45c5969060ff5bc519c9631a6301|JXSS1900010|JXSS1900010|JXSS1900010.pdf
a167a67dbcf7104c67728289440090b7|JXSS1900004|JXSS1900004|阿替利珠单抗注射液（JXSS1900004）-申请上市技术审评报告.pdf
3d855bae34206931eeb2e2969f99c2b9|JXSS1900005|JXSS1900005|达依泊汀α注射液（JXSS1900005-09）申请上市技术审评报告.pdf
f437e04d8bae7f63b42d2ecacc4e6a27|JXSS1900006|JXSS1900006|达依泊汀α注射液（JXSS1900005-09）申请上市技术审评报告.pdf
b5cb37ed72071bcc7e8f6ec4be440198|JXSS1900007|JXSS1900007|达依泊汀α注射液（JXSS1900005-09）申请上市技术审评报告.pdf
d6b7624b7679eac68572318eea177ab4|JXSS1900008|JXSS1900008|达依泊汀α注射液（JXSS1900005-09）申请上市技术审评报告.pdf
2f331c8b5929596647777b61a63ce790|JXSS1900009|JXSS1900009|达依泊汀α注射液（JXSS1900005-09）申请上市技术审评报告.pdf
a08ae298aa9bc35260d1d98fbd467748|CXHS1900005|CXHS1900005|CXHS1900005.pdf
1846a424e22d68d03a13878bf3ecd9bb|CXHS1900006|CXHS1900006|CXHS1900005.pdf
f567104897d80f4dbd678b80fe1cf576|CXSS1900006|CXSS1900006|CXSS1900006.pdf
08501fd847d34ede963316001876046c|JXSS1900003|JXSS1900003|注射用维拉苷酶α(JXSS1900003)--申请上市技术审评报告.pdf
0d5cf3f08b390641259591ebffe7c609|JXHS1900028|JXHS1900028|西尼莫德片（JXHS1900028-29）申请上市技术审评报告.pdf
e4d634ff1fc5b21dbf83a8c18fcd4490|JXHS1900029|JXHS1900029|西尼莫德片（JXHS1900028-29）申请上市技术审评报告.pdf
8b0d038482e4156394c88c9fabd428a6|JXSS1900001|JXSS1900001|纳武利尤单抗   ( JXSS1900001-2）申请上市技术审评报告.pdf
c6b27e99194e0a75129ccb73eb4d01f0|JXSS1900002|JXSS1900002|纳武利尤单抗   ( JXSS1900001-2）申请上市技术审评报告.pdf
2586278f02beded98210461f5c5e809d|CXSS1900004|CXSS1900004|贝伐珠单抗注射液（CXSS1900004）申请上市技术审评报告.pdf
079b86c8d3661237db59545a554a309c|CXSS1900005|CXSS1900005|静注人免疫球蛋白（pH4）（CXSS1900005）-申请上市技术审评报告.pdf
64c1fdda478a786c9376ca3b1088146d|JXHS1900013|JXHS1900013|利伐沙班片（JXHS1900013）申报上市注册申请技术审评报告.pdf
e5dc207dd288625ce6620bd866e5dc1c|CXSS1900003|CXSS1900003|Sabin株脊髓灰质炎灭活疫苗（Vero细）（CXSS1900003）-申请上市技术审评报告.pdf
a49e59c69566e33334cb5764dca60fcf|CXSS1900001|CXSS1900001|CXSS1900001.pdf
19b8c49f550c77ab2dab5780f4c8b8c7|JXHS1900009|JXHS1900009|JXHS1900009-10_盐酸二甲双胍片_报告.pdf
df6b5de9fa2f64c0b4a97e91ed9ceaad|JXHS1900010|JXHS1900010|JXHS1900009-10_盐酸二甲双胍片_报告.pdf
c148c8d470a2be43b947b5a94e95a4a0|JXHS1900001|JXHS1900001|盐酸羟考酮缓释片（JXHS1900001）-申请上市技术审评报告.pdf
a7ac40a6174181b2e9624899a767abc8|JXHS1900002|JXHS1900002|盐酸羟考酮缓释片（JXHS1900002）-申请上市技术审评报告.pdf
a07be9317d413bf97834c417030b58fe|JXHS1900005|JXHS1900005|盐酸羟考酮缓释片（JXHS1900005）-申请上市技术审评报告.pdf
6b75f5ee72886e6d3063903216f1b301|CXHS1900001|CXHS1900001|恩替卡韦颗粒（CXHS1900001）申请上市技术审评报告.pdf
fe8fd9e503e370ec39d71d6261eece89|CXHS1900003|CXHS1900003|海博麦布片（CXHS1900003-04）申请上市技术审评报告.pdf
777200c26eba29cbf158a9690247aff2|CXHS1900004|CXHS1900004|海博麦布片（CXHS1900003-04）申请上市技术审评报告.pdf
ebc38c964267c950370ec0764752e373|JXHS1900008|JXHS1900008|塞瑞替尼胶囊 （JXHS1900008）申请上市技术审评报告.pdf
06d71b444b4ba3adb8b8909eca70d3cf|JXSS1800043|JXSS1800043|阿达木单抗注射液（JXSS1800043）申请上市技术审评报告.pdf
e9dcba429b4f0ee8b4646964ec9e3641|JXSS1800044|JXSS1800044|阿达木单抗注射液 (JXSS1800044)申请上市技术审评报告.pdf
7847e7b382c03c5720c8bc5ae78a587b|JXHS1800081|JXHS1800081|甲磺酸达拉非尼胶囊（JXHS1800081-82）申请上市技术审评报告.pdf
c6cff11df45b162577cb8493d7eb4edc|JXHS1800082|JXHS1800082|甲磺酸达拉非尼胶囊（JXHS1800081-82）申请上市技术审评报告.pdf
2fbd1d74c8ffd59d85c0ead9f5f6212d|JXHS1800083|JXHS1800083|曲美替尼片（JXHS1800083-84）申请上市技术审评报告.pdf
2f5796c6a5d3341120add9060d301ff2|JXHS1800084|JXHS1800084|曲美替尼片（JXHS1800083-84）申请上市技术审评报告.pdf
729820ee8c79a13a5f953a58106eaf41|JXSS1800042|JXSS1800042|帕妥珠单抗注射液   (JXSS1800042）申请上市技术审评报告.pdf
15163c629cb0dc575fe9fb978120d285|CXHS1800045|CXHS1800045|盐酸恩沙替尼胶囊（CXHS1800045-46)-申请上市技术审评报告.pdf
695eb3345dc76e5563bd0ddd7449b665|CXHS1800046|CXHS1800046|盐酸恩沙替尼胶囊（CXHS1800045-46)-申请上市技术审评报告.pdf
1ecfa27a5ee9edd5341bb10f521a016c|JXHS1800080|JXHS1800080|普拉曲沙注射液（JXHS1800080）申请上市技术审评报告.pdf
c84cbbd25f228cff4658937fe4abc5b0|JXHS1800074|JXHS1800074|JXHS1800074.pdf
069af50062adb981f471c4baec433594|JXHS1800078|JXHS1800078|JXHS1800078.pdf
d8903479f5ab87f7092493a6b34d77f0|JXSS1800040|JXSS1800040|度伐利尤单抗注射液(JXSS1800040-41)申请上市技术审评报告.pdf
4a72c21deeb2ca48045c2d61debb2a82|JXSS1800041|JXSS1800041|度伐利尤单抗注射液(JXSS1800040-41)申请上市技术审评报告.pdf
3c0877f9e047f78e7ffdbe8d00854ba2|JXSS1800039|JXSS1800039|重组带状疱疹疫苗（JXSS1800039）申请上市技术审评报告.pdf
49e204cc18b7261d066685823fed6bcc|CXSS1800030|CXSS1800030|四价流感病毒裂解疫苗（CXSS1800030）申请上市技术审评报告.pdf
f2d601a5a4b53abe4a94e7aee411cc82|CXHS1800043|CXHS1800043|甲苯磺酸尼拉帕利胶囊（CXHS1800043）申请上市技术审评报告.pdf
eb73ce805a585475aa4718b41ddd0cb3|JXHS1800072|JXHS1800072|比索洛尔氨氯地平片（JXHS1800072）申请上市技术审评报告.pdf
f95ca65088d93a2c95ad496fd531fd72|CXSS1800029|CXSS1800029|静注人免疫球蛋白（pH4）   ( CXSS1800029 ) -申请上市技术审评报告.pdf
d13bfedc49ce0a9e6636b2c6cb9ee994|JXHS1800071|JXHS1800071|拉考沙胺注射液（JXHS1800071）申请上市技术审评报告.pdf
039809a7c8f53da21e635cfcf2fc8050|JXSS1800030|JXSS1800030|利拉鲁肽注射液（JXSS1800030 ）申请上市技术审评报告.pdf
165f17e35fa9f3b21eeeabf35f126fdd|JXSS1800032|JXSS1800032|阿利西尤单抗注射液(JXSS1800032-33)申报上市注册申请技术审评报告.pdf
ff4622e273087a18068924c859846669|JXSS1800033|JXSS1800033|阿利西尤单抗注射液(JXSS1800032-33)申报上市注册申请技术审评报告.pdf
5a94476e78e2e9af2b42fea6cd384c10|JXSS1800034|JXSS1800034|阿利西尤单抗注射液(JXSS1800034-35)申报上市注册申请技术审评报告.pdf
1f754c8e16227d3e8bc8d4fde2f90f06|JXSS1800035|JXSS1800035|阿利西尤单抗注射液(JXSS1800034-35)申报上市注册申请技术审评报告.pdf
b1fb2a42c5cbdfe05aaccc66b9fa4ad7|JXHS1800068|JXHS1800068|拉考沙胺糖浆（JXHS1800068）申请上市技术审评报告.pdf
7265617dcdad8e6a5a39077ee6e745ff|JXHS1800069|JXHS1800069|艾托格列净片（JXHS1800069）申请上市技术审评报告.pdf
aa40ef45ae1fe4871b9ae167e55cf041|JXHS1800060|JXHS1800060|乌美溴铵吸入粉雾剂（JXHS1800060）申请上市技术审评报告.pdf
b8fe3435c9ac61567bf48a92aeae59e0|CXHS1800039|CXHS1800039|盐酸安罗替尼胶囊(CXHS1800039-41)-申请上市技术审评报告.pdf
4dad41b53a03727c812e2baf1f63006c|CXHS1800040|CXHS1800040|盐酸安罗替尼胶囊(CXHS1800039-41)-申请上市技术审评报告.pdf
72bf11cab752f1385fc13260dff6d1fb|CXHS1800041|CXHS1800041|盐酸安罗替尼胶囊(CXHS1800039-41)-申请上市技术审评报告.pdf
26b582388d2795bb816bc65f36b2f603|JXHS1800065|JXHS1800065|比克恩丙诺片（JXHS1800065）申请上市技术审评报告.pdf
70d73e8c25dbf00526be491eb0cadd35|CYHS1800419|CYHS1800419|盐酸氨溴索喷雾剂 （CYHS1800419）申请上市技术审评报告.pdf
92c1f191bcc84b3ba2ff7b56eff85288|CXZS1700008|CXZS1700008|桑枝总生物碱片（CXZS1700008）申请上市技术审评报告.pdf
9a4ef02a05678d9683701f182e87eeb1|CXHS1800035|CXHS1800035|注射用苯磺酸瑞马唑仑（CXHS1800035）申请上市技术审评报告.pdf
56076216e096639589b2c8c5a3aed0b6|CXSS1800027|CXSS1800027|阿达木单抗注射液（CXSS1800027）申请上市技术审评报告.pdf
b3dba11fc6445899c30a995e1024a631|JXHS1800057|JXHS1800057|异麦芽糖酐铁注射液（JXHS1800056-58）-申请上市技术审评报告.pdf
eb041ac044f1d120b7067a34f2fe21ef|JXHS1800058|JXHS1800058|异麦芽糖酐铁注射液（JXHS1800056-58）-申请上市技术审评报告.pdf
50b98609b06090a2b886f081f7862f74|JXSS1800029|JXSS1800029|帕博利珠单抗注射液（JXSS1800029）-申请上市技术审评报告.pdf
9a8cb5405ae33833d3edebd023ccfa8a|JXHS1800056|JXHS1800056|异麦芽糖酐铁注射液（JXHS1800056-58）-申请上市技术审评报告.pdf
0d418220b0bfaf6df326db4a536f936f|JXHS1800054|JXHS1800054|甲磺酸奥希替尼片(JXHS1800054-55)申请上市技术审评报告.pdf
515a253f78b02c49823b83bb149b2a23|JXHS1800055|JXHS1800055|甲磺酸奥希替尼片(JXHS1800054-55)申请上市技术审评报告.pdf
bb5fbd1880b4256c5d7405b2d5105202|JXSS1800026|JXSS1800026|地舒单抗注射液（JXSS1800026）申请上市技术审评报告.pdf
f90a915d73040b8b7370bf230c7bc038|CXHS1800030|CXHS1800030|泽布替尼胶囊（CXHS1800030）申请上市技术审评报告.pdf
05f9cd1c9173b73d2c9076232233a2d8|JXSS1800025|JXSS1800025|帕博利珠单抗注射液（JXSS1800025）-申请上市技术审评报告.pdf
482e06bf4de70a8c2a51f90388a57d96|JXSS1800023|JXSS1800023|达雷妥尤单抗注射液（JXSS1800023-24）申请上市技术审评报告.pdf
cd1a8c8a775fd105595cc9d8e9a32414|JXSS1800024|JXSS1800024|达雷妥尤单抗注射液（JXSS1800023-24）申请上市技术审评报告.pdf
d8145651eb00fe7277e690840c949382|JXSS1800021|JXSS1800021|注射用阿加糖酶β   ( JXSS1800021-022)申请上市技术审评报告.pdf
05f0f727ac77fdb35523014457bd7ebb|JXSS1800022|JXSS1800022|注射用阿加糖酶β   ( JXSS1800021-022)申请上市技术审评报告.pdf
4135788eaab6bbc45ab65b444bf31033|JXHS1800052|JXHS1800052|吡仑帕奈片（JXHS1800052-53）申请上市技术审评报告.pdf
73821092079b7917ee5b045c8ce06204|JXHS1800053|JXHS1800053|吡仑帕奈片（JXHS1800052-53）申请上市技术审评报告.pdf
f07fc61d803df74a9e4185f5a2fdea5f|CXSS1800026|CXSS1800026|冻干人用狂犬病疫苗（Vero细胞）（CXSS1800026）-申请上市技术审评报告.pdf
5432ed51c90f7f08ecbb40d2bd905e6e|CXHS1800029|CXHS1800029|注射用磷丙泊酚二钠（CXHS1800029）-申请上市技术审评报告.pdf
c7cb6e54f557db10eea7eb7984bce11e|JXHS1800040|JXHS1800040|JXHS1800040.pdf
0e3cb8cea5d09c5235a69e34220f8928|JXHS1800039|JXHS1800039|马来酸奈拉替尼片（JXHS1800039）-申请上市技术审评报告.pdf
7a6bd7c7dea1bd59dc975f2b9ed43674|JXSS1800020|JXSS1800020|帕妥珠单抗注射液   ( JXSS1800020）申请上市技术审评报告.pdf
dabe2c9f72e47c59ca0258e7960b28e8|JXSS1800019|JXSS1800019|司库奇尤单抗注射液（JXSS1800019）申请上市技术审评报告.pdf
786fd25e0b01ab5f0249ecabb84f4892|JXHS1800034|JXHS1800034|布地格福吸入气雾剂（JXHS1800034-35）申请上市技术审评报告.pdf
0afe1020ecceb03da0d196dc15695bd2|JXHS1800035|JXHS1800035|布地格福吸入气雾剂（JXHS1800034-35）申请上市技术审评报告.pdf
bbeafe36efd475757e6be19596a25810|JXSS1800018|JXSS1800018|帕博利珠单抗注射液（JXSS1800018）申请上市技术审评报告.pdf
dbcefb93bf5a6de7a7b0ff507ec1cf5e|CXSS1800020|CXSS1800020|重组结核杆菌融合蛋白（EC）（CXSS1800020-22) 申请上市技术审评报告.pdf
1f4aa08a4d695eb822cc0f54d6674b2a|CXSS1800021|CXSS1800021|重组结核杆菌融合蛋白（EC）（CXSS1800020-22) 申请上市技术审评报告.pdf
8294e7c7cfa82d74e490df55cdebe7ac|CXSS1800022|CXSS1800022|重组结核杆菌融合蛋白（EC）（CXSS1800020-22) 申请上市技术审评报告.pdf
eb738bed1e065ba10534d0e545e24e9c|CXSS1800023|CXSS1800023|注射用伊尼妥单抗（CXSS1800023）-申请上市技术审评报告.pdf
8dee7d6a6997ccfac394117971d03915|CXHS1800025|CXHS1800025|盐酸安罗替尼胶囊(CXHS1800025-27)申请上市技术审评报告.pdf
4d9bd4e61be50ae0ea95aaf2cb8e71c5|CXHS1800026|CXHS1800026|盐酸安罗替尼胶囊(CXHS1800025-27)申请上市技术审评报告.pdf
87a46f76d599d9786597233612bc84a4|CXHS1800027|CXHS1800027|盐酸安罗替尼胶囊(CXHS1800025-27)申请上市技术审评报告.pdf
ff8e4b851ea62ef3021a810f85accfa2|CXSS1800019|CXSS1800019|替雷利珠单抗注射液（CXSS1800019）申请上市技术审评报告.pdf
e59793a5c4c6103785520d5893e9f320|JXHS1800032|JXHS1800032|诺西那生钠注射液（JXHS1800032）申请上市技术审评报告.pdf
8fadf13a044a5dfc74786fcb5971066c|JXSS1800017|JXSS1800017|注射用A型肉毒毒素（JXSS1800017）申请上市技术审评报告.pdf
be067217a584f24eab8a206650c190c6|CXHS1800024|CXHS1800024|泽布替尼胶囊（CXHS1800024）申请上市技术审评报告.pdf
d222afc02dedeacb9c820d86891616c9|CXHS1800021|CXHS1800021|奥氮平口溶膜（CXHS1800021-22）申请上市技术审评报告.pdf
86d072611faa84a3e98284621cc6f79f|CXHS1800022|CXHS1800022|奥氮平口溶膜（CXHS1800021-22）申请上市技术审评报告.pdf
6c363bf4f1a7e82e970c96994eab46a0|CXSS1800017|CXSS1800017|贝伐珠单抗注射液（CXSS1800017）申请上市技术审评报告.pdf
2379b213f1683f93f963a98b620daadf|JXHS1800029|JXHS1800029|盐酸曲唑酮缓释片（JXHS1800029-30）申请上市技术审评报告.pdf
f4421653e41b11365d1513601085a420|JXHS1800030|JXHS1800030|盐酸曲唑酮缓释片（JXHS1800029-30）申请上市技术审评报告.pdf
1177b915f28307ced4af85343cc41971|CXHS1800020|CXHS1800020|盐酸拉维达韦片（CXHS1800020）申请上市技术审评报告.pdf
14d8032afac489db65006fda51e9b2b2|JXSS1800016|JXSS1800016|阿加糖酶α注射用浓溶液(JXSS1800016)-申请上市技术审评报告.pdf
9fbb79d3d5385e780632a558bb985bad|CXHS1800018|CXHS1800018|左奥硝唑氯化钠注射液（CXHS1800018）申请上市技术审评报告.pdf
5f3e76798f9830f86a80c0cf8b40411b|JXSS1800015|JXSS1800015|阿巴西普注射液（JXSS1800015）申请上市技术审评报告.pdf
916b54d824e7172635bf81e069817f5e|CXHS1800016|CXHS1800016|甲磺酸氟马替尼片 ( CXHS1800016-17）申请上市技术审评报告.pdf
7b230b8a2b8dc3797df483a3c25bfa78|CXHS1800017|CXHS1800017|甲磺酸氟马替尼片 ( CXHS1800016-17）申请上市技术审评报告.pdf
3fc136b6c52f333ba94db2b2bf966b1f|JXHS1800027|JXHS1800027|美阿沙坦钾片（JXHS1800027-28）申请上市技术审评报告.pdf
5059aa0583231b2191a29c0e9eab23d9|JXHS1800028|JXHS1800028|美阿沙坦钾片（JXHS1800027-28）申请上市技术审评报告.pdf
7aa7f7327bdb9eb38aa73d47667e4fa3|CXSS1800014|CXSS1800014|四价流感病毒裂解疫苗（CXSS1800014）-申请上市技术审评报告.pdf
6b3360f065771de62ba9b21e6308d594|JXHS1800026|JXHS1800026|波生坦分散片 （JXHS1800026）申请上市技术审评报告.pdf
9c5d2a08a5261f9bca4d4f96d54f122d|CXHS1800013|CXHS1800013|罗沙司他胶囊（CXHS1800013-14）申请上市技术审评报告.pdf
4d29f2055657a5afcb09d0427dbf7433|CXHS1800014|CXHS1800014|罗沙司他胶囊（CXHS1800013-14）申请上市技术审评报告.pdf
e753d7310b445f661c83d490d5f41bbe|JXHS1800025|JXHS1800025|氟替美维吸入粉雾剂（JXHS1800025）申请上市技术审评报告.pdf
c1937f145d9ca92286b3a15fe7351a26|CXHS1800007|CXHS1800007|盐酸可洛派韦胶囊（CXHS1800007）申请上市技术审评报告.pdf
a1a75d46246fc7d0acec9267425d07b2|CXSS1800013|CXSS1800013|重组人胰岛素注射液(CXSS1800013)申请上市技术审评报告.pdf
723b988e02e241bfdb20cc82ed65ceb8|CXSS1800012|CXSS1800012|人凝血因子Ⅷ（CXSS1800012）-申请上市技术审评报告.pdf
e0b8a210ad2a546ae7b6a305963613e1|JXSS1800013|JXSS1800013|阿达木单抗注射液（JXSS1800013-14）申报上市注册申请技术审评报告.pdf
70f1138690ce71da973841af0af2b5ca|JXSS1800014|JXSS1800014|阿达木单抗注射液（JXSS1800013-14）申报上市注册申请技术审评报告.pdf
a54c630542816e069edc5e0a936f803e|JXHS1800023|JXHS1800023|达可替尼片（JXHS1800023-24）申请上市技术审评报告.pdf
2e536f839d720fb53fcd6e8ada8089ea|JXHS1800024|JXHS1800024|达可替尼片（JXHS1800023-24）申请上市技术审评报告.pdf
60bb02192714ea05d2de78b06ab835f5|JXHS1800021|JXHS1800021|盐酸安非他酮缓释片（II）（JXHS1800021-22）申请上市技术审评报告.pdf
916b44ce8064ba403e86aace8a34ddee|JXHS1800022|JXHS1800022|盐酸安非他酮缓释片（II）（JXHS1800021-22）申请上市技术审评报告.pdf
05f91dab2dce1845eb165e3a343d9ac1|CXSS1700035|CXSS1700035|鼻喷冻干流感减毒活疫苗（CXSS1700035）-申请上市技术审评报告.pdf
fc0271ce2ed9780588fbe9c9a90aa128|JXSS1800011|JXSS1800011|德谷门冬双胰岛素注射液（JXSS1800011、12）申请上市技术审评报告.pdf
e3615c06744c60642d5573038fcf102d|JXSS1800012|JXSS1800012|德谷门冬双胰岛素注射液（JXSS1800011、12）申请上市技术审评报告.pdf
c142262aa78c1e034bac10b88aaea037|CXSS1800010|CXSS1800010|注射用母牛分枝杆菌（CXSS1800010）-申请上市技术审评报告.pdf
21109a6a36bf1f784614dce804c367a6|JXSS1800010|JXSS1800010|依洛尤单抗注射液(JXSS1800010)申报上市注册申请技术审评报告.pdf
f83a27b7934604cd80b99f4937d1c9d6|CXSS1800009|CXSS1800009|注射用卡瑞利珠单抗（CXSS1800009）申请上市技术审评报告.pdf
19aad566c10b15f1f22fe34cb00ea3c0|JXSS1800008|JXSS1800008|九价人乳头瘤病毒疫苗（酿酒酵母）(JXSS1800008-9) 申请上市技术审评报告.pdf
169978af656985edca0c2550db918154|JXSS1800009|JXSS1800009|九价人乳头瘤病毒疫苗（酿酒酵母）(JXSS1800008-9) 申请上市技术审评报告.pdf
691a61e74feff42d29c03679d8707461|CXSS1800008|CXSS1800008|信迪利单抗注射液（CXSS1800008）申请上市技术审评报告.pdf
8e4ecc2cf3b7d591b6b9697028f2668b|CXHS1700029|CXHS1700029|注射用左亚叶酸（CXHS1700029-30）-申请上市技术审评报告.pdf
9dfae163320a6bd8880e199474127d69|CXHS1700030|CXHS1700030|注射用左亚叶酸（CXHS1700029-30）-申请上市技术审评报告.pdf
b7c611441f43971437709498fe827530|CXSS1800007|CXSS1800007|人凝血因子Ⅸ(CXSS1800007)-申请上市技术审评报告.pdf
9282169b3fd132c0b0c68120cd612a09|JXHS1800019|JXHS1800019|格卡瑞韦哌仑他韦片（JXHS1800019）申请上市审评报告.pdf
efa2afc0c78143e260ea5f24cd2fe7b4|JXSS1800005|JXSS1800005|注射用贝利尤单抗（JXSS1800005-6）申请上市技术审评报告.pdf
a655ce802a4bdc18952d1302d44571c3|JXSS1800006|JXSS1800006|注射用贝利尤单抗（JXSS1800005-6）申请上市技术审评报告.pdf
03ae188489c740a8c4ffd4e398cbf5ab|CXZS1800001|CXZS1800001|益气通窍丸（CXZS1800001）申请上市技术审评报告.pdf
3e423b48810bd85c35946b1821a8dd8f|JXHS1800014|JXHS1800014|醋酸兰瑞肽缓释注射液（预充式）（JXHS1800014-16）申请上市技术审评报告.pdf
665374dbfec3514fa57fea3d078e5aba|JXHS1800016|JXHS1800016|醋酸兰瑞肽缓释注射液（预充式）（JXHS1800014-16）申请上市技术审评报告.pdf
a0e02c4e753ea5b8cc1915103a6bebdc|JXHS1800017|JXHS1800017|富马酸伏诺拉生片（JXHS1800017-18）申报上市注册申请技术审评报告.pdf
7d0dee9d7c1f7117bc60f5be6dffbac7|JXHS1800018|JXHS1800018|富马酸伏诺拉生片（JXHS1800017-18）申报上市注册申请技术审评报告.pdf
e88fe139e9eee18a32b03e2f41e64874|JXSS1800003|JXSS1800003|培塞利珠单抗注射液（JXSS1800003）申请上市技术审评报告.pdf
c7f48e79776c40c1662aa8aea43c619d|CXHS1800005|CXHS1800005|优替德隆注射液（CXHS1800005）申请上市技术审评报告.pdf
8bb4d647757458faceda78e3e2c04974|CXZS1700004|CXZS1700004|黄蜀葵花总黄酮口腔贴片申请上市技术审评报告.pdf
a4fd8a4ebee8915df3fd3e6f38e2b8bf|JXHS1800012|JXHS1800012|艾地骨化醇软胶囊（JXHS1800012-13）-申请上市技术审评报告.pdf
c678116f59f7be08e16fbde7865bf18f|JXHS1800013|JXHS1800013|艾地骨化醇软胶囊（JXHS1800012-13）-申请上市技术审评报告.pdf
a2d7b06fc74eef52b9aca67792272230|CXHS1800002|CXHS1800002|注射用甲苯磺酸瑞马唑仑（CXHS1800002）申请上市技术审评报告.pdf
e22cdd59b8f7264a57e5ac01e479c676|JXHS1800011|JXHS1800011|醋酸阿比特龙片（JXHS1800011）申请上市技术审评报告.pdf
81bc86adc3e1727b37f9cc604b39f0ae|CXSS1800006|CXSS1800006|特瑞普利单抗注射液（CXSS1800006）申请上市技术审评报告.pdf
3a94c7fd3c49daa494cf19ad9bb2fc15|JXHS1800009|JXHS1800009|巴瑞替尼片（JXHS1800009）申请上市技术审评报告.pdf
9db02be28434b90867ad4eaf103c3dfc|JXHS1800004|JXHS1800004|盐酸托莫西汀口服溶液 (JXHS1800004) 申请上市技术审评报告.pdf
50bda7e674ba7a80a6ad7a8462791084|CXSS1600012|CXSS1600012|精蛋白重组人胰岛素注射液（CXSS1600012）申请上市技术审评报告.pdf
6974c2bacbac2963c8416eb46845b72b|CXSS1600013|CXSS1600013|精蛋白重组人胰岛素注射液（预混3070）（CXSS1600013）申请上市技术审评报告.pdf
d9c496890241728e5b612b672afa2bac|JXSS1800002|JXSS1800002|帕博利珠单抗注射液（JXSS1800002）申请上市技术审评报告.pdf
e90eed7501d012e68b2af6f98ed8e10f|JXHS1800001|JXHS1800001|盐酸阿来替尼胶囊(JXHS1800001)-申请上市技术审评报告.pdf
7201cda84b6b1ab43e6ab8008bb8ea72|JXSS1800001|JXSS1800001|人血白蛋白（JXSS1800001）-申请上市技术审评报告.pdf
a2fae07c032d865eb75369ccbfd144ac|CXSS1700034|CXSS1700034|A群C群脑膜炎球菌多糖结合疫苗（CXSS1700034）-申请上市技术审评报告.pdf
4272946171cdf22cf1ec7c3638941f9b|CXSS1800001|CXSS1800001|CXSS1800001.pdf
23d16ce69b064112119b10a3e27e92b3|CXSS1700028|CXSS1700028|门冬胰岛素注射液（CXSS1700028-29）申请上市技术审评报告.pdf
8701fc4b60e89331e4e5459d829d47a7|CXSS1700029|CXSS1700029|门冬胰岛素注射液（CXSS1700028-29）申请上市技术审评报告.pdf
db99c6d4975414a52ee70de09ab63595|CXSS1700030|CXSS1700030|门冬胰岛素30注射液（CXSS1700030-31）申请上市技术审评报告.pdf
2827e9f9ba53840647a152f6f1da59f3|CXSS1700031|CXSS1700031|门冬胰岛素30注射液（CXSS1700030-31）申请上市技术审评报告.pdf
704ecf5bcf3b18a603046b639c4a048f|CXZS1700002|CXZS1700002|芍麻止痉颗粒（CXZS1700002）申请上市技术审评报告.pdf
1ecbf16da13e5a84fd5953bd84f8c20d|JXSS1700018|JXSS1700018|帕妥珠单抗注射液   ( JXSS1700018）申请上市技术审评报告.pdf
f83af93e96139b56f01b13759bf3a756|JXHS1700055|JXHS1700055|来迪派韦索磷布韦片 （JXHS1700055）申请上市技术审评报告.pdf
0ef6f58c12e2232786824c7524a1f0c7|CXSS1700026|CXSS1700026|利妥昔单抗注射液（CXSS1700026）申请上市技术审评报告.pdf
7a114f557fe0f3680a3a346c97b67757|JXHS1700053|JXHS1700053|塞瑞替尼胶囊（JXHS1700053）申请上市技术审评报告.pdf
69b9149e2b42fa4a0074c496cceaccda|JXSS1700017|JXSS1700017|注射用A型肉毒毒素（JXSS1700017）申请上市技术审评报告.pdf
3c567556e8bf654f691b119901a8c819|CXHS1700025|CXHS1700025|聚乙二醇洛塞那肽注射液（CXHS1700025-26）申请上市技术审评报告.pdf
1a6a66407833a5d3bf01b4cf2fe6fab6|CXHS1700026|CXHS1700026|聚乙二醇洛塞那肽注射液（CXHS1700025-26）申请上市技术审评报告.pdf
d650421083a3845e66c4bba56c07ea71|JXHS1700048|JXHS1700048|甲磺酸艾立布林注射液（JXHS1700048）申请上市技术审评报告.pdf
ae13ee41417952bb20d70d2a6a5dcf54|JXHS1700049|JXHS1700049|甲苯磺酸艾多沙班片（JXHS1700049-51）申请上市技术审评报告.pdf
b930c27a9fefcaeb5e9ae8ffbb6bfd1d|JXHS1700050|JXHS1700050|甲苯磺酸艾多沙班片（JXHS1700049-51）申请上市技术审评报告.pdf
bce1197019495b8faf0f0da142294072|JXHS1700051|JXHS1700051|甲苯磺酸艾多沙班片（JXHS1700049-51）申请上市技术审评报告.pdf
3f33d629d01afc82ee61350938aa2089|JXSL1700076|JXSL1700076|艾美赛珠单抗注射液（JXSL1700076-79）申请上市技术审评报告.pdf
bc7f998575b3ba7163ba7bf13336d9ca|JXSL1700077|JXSL1700077|艾美赛珠单抗注射液（JXSL1700076-79）申请上市技术审评报告.pdf
30176e7a1395d6b670178b2ad0dbb457|JXSL1700078|JXSL1700078|艾美赛珠单抗注射液（JXSL1700076-79）申请上市技术审评报告.pdf
b33fb59456a00a98e48367afbf3a1044|JXSL1700079|JXSL1700079|艾美赛珠单抗注射液（JXSL1700076-79）申请上市技术审评报告.pdf
a024a16d26e6a292bd229a8d8fb86ea3|JXHS1700046|JXHS1700046|奥拉帕利片（JXHS1700046-47）申请上市技术审评报告.pdf
1be4df01a5503faf2d20f7af4803bc27|JXHS1700047|JXHS1700047|奥拉帕利片（JXHS1700046-47）申请上市技术审评报告.pdf
3174006c97d39ac167b1f5e965a3cc38|CXHS1700022|CXHS1700022|苯环喹溴铵鼻喷雾剂 （CXHS1700022）申请上市技术审评报告.pdf
bfb9a01042e73c454fbd931e54a586ad|CXSS1700023|CXSS1700023|注射用重组特立帕肽（CXSS1700023）申请上市技术审评报告.pdf
341273b70a544b2786be75f40d0d8fca|CXSS1700024|CXSS1700024|人凝血酶原复合物（CXSS1700024）-申请上市技术审评报告.pdf
714429507863ca27b543ef9bd1da4490|CXSS1700025|CXSS1700025|人凝血酶原复合物（CXSS1700025）-申请上市技术审评报告.pdf
0a48391ba86b79f8f10edeb9bae848e7|JXHS1700042|JXHS1700042|甲磺酸仑伐替尼胶囊（JXHS1700042）申请上市技术审评报告.pdf
8c9dfa5c4661f7828273b14560dad995|CXHS1700019|CXHS1700019|罗沙司他胶囊（CXHS1700019-20）申请上市技术审评报告.pdf
0a9a7e62e0830029409d4d5044660529|CXHS1700020|CXHS1700020|罗沙司他胶囊（CXHS1700019-20）申请上市技术审评报告.pdf
5947a31d5c5f7fe92fddf84983cae642|JXSS1700015|JXSS1700015|纳武利尤单抗注射液（JXSS1700015~6）申请上市技术审评报告.pdf
9e83777239a002f2831d7ce46d0a6dc2|JXSS1700016|JXSS1700016|纳武利尤单抗注射液（JXSS1700015~6）申请上市技术审评报告.pdf
87616d25e4302b2f5aa9217922be0088|JXHS1700041|JXHS1700041|噻托溴铵奥达特罗吸入喷雾剂（JXHS1700041）申请上市技术审评报告.pdf
e4175a8d43e4697efea10bd00acf5f9a|JXSS1700013|JXSS1700013|西妥昔单抗注射液（JXSS1700013）申请上市技术审评报告.pdf
742a0e227cbd6c79d71636683af50f81|JXSS1700014|JXSS1700014|依洛尤单抗注射液(JXSS1700014)申报上市注册申请技术审评报告.pdf
5d69937f014e73394a7b29ee458ee259|CXSS1700018|CXSS1700018|重组人生长激素注射液（CXSS1700018-19）申请上市技术审评报告.pdf
e495f50c2c50cc71276c483074020da7|CXSS1700019|CXSS1700019|重组人生长激素注射液（CXSS1700018-19）申请上市技术审评报告.pdf
7a1d19ef0d8741cd1accec826ad63647|JXHL1700182|JXHL1700182|JXHL1700182.pdf
faa100f3b3db92f133065b4bcb9ab6e7|JXHL1700186|JXHL1700186|富马酸丙酚替诺福韦片（JXHL1700186）申请上市技术审评报告.pdf
59d6708a44cf9eac534b621527bf969f|JXHS1700036|JXHS1700036|枸橼酸西地那非口崩片（JXHS1700036）申请上市技术审评报告.pdf
91dc5188527ba0991faf17841d06d65c|JXSS1700010|JXSS1700010|JXSS1700010.pdf
a091c0cb4f0de4e043142e2824184122|JXHL1700165|JXHL1700165|JXHL1700165.pdf
d9180f3a946b8acf1c629ffa6c719fa4|JXHL1700161|JXHL1700161|普乐沙福注射液（JXHS1500091、JXHL1700161）申请上市技术审评报告.pdf
2e0e9a93c5fcce678ad2c86a72a928d1|CXSS1700014|CXSS1700014|四价流感病毒裂解疫苗（CXSS1700014）申请上市技术审评报告.pdf
2d50316297f56adee679911312225e0e|JXHS1700035|JXHS1700035|艾尔巴韦格拉瑞韦片（JXHS1700035）申请上市技术审评报告.pdf
ac194c9830f4499197b625d6c3dfdbd9|CXHS1700013|CXHS1700013|马来酸吡咯替尼片(CXHS1700013-14)申请上市技术审评报告.pdf
1e0a4bb47ad976e5c6c0fb23b06e6d07|CXHS1700014|CXHS1700014|马来酸吡咯替尼片(CXHS1700013-14)申请上市技术审评报告.pdf
2a3974a6ea1bbbeff4ebaf435fde7617|JXHL1700151|JXHL1700151|哌柏西利胶囊(JXHL1700151-153、JXHL1500266-268)申请上市技术审评报告.pdf
f70266bae115655cb7b7f2bfb6898fa9|JXHL1700152|JXHL1700152|哌柏西利胶囊(JXHL1700151-153、JXHL1500266-268)申请上市技术审评报告.pdf
ca5e7e288d21921828d25ccefe80abda|JXHL1700153|JXHL1700153|哌柏西利胶囊(JXHL1700151-153、JXHL1500266-268)申请上市技术审评报告.pdf
3bf1651fe2688a0c4d1d599bbb90cbae|CXHS1700006|CXHS1700006|注射用艾司奥美拉唑钠(CXHS1700006)申请上市技术审评报告.pdf
4be6032d1f5ab752489a01a14a89a44e|JXSL1700046|JXSL1700046|度拉糖肽注射液(JXSL1700046-47)申请上市技术审评报告.pdf
f9d85d5e978d42c6667da0822887b729|JXSL1700047|JXSL1700047|度拉糖肽注射液(JXSL1700046-47)申请上市技术审评报告.pdf
a4e86e1bbe53421f5184cb03bb5310d1|CXHS1700005|CXHS1700005|苹果酸奈诺沙星氯化钠注射液 （CXHS1700005）申请上市技术审评报告.pdf
de132d10dcdc8db3c274bd3a2559f37f|JXHS1700034|JXHS1700034|注射用比伐芦定（JXHS1700034）申请上市技术审评报告.pdf
95645a303f8a075356743e58c531a61f|CXHS1700008|CXHS1700008|呋喹替尼胶囊（CXHS1700008-09）申请上市技术审评报告.pdf
45889de7a22f4f598315862c17dac899|CXHS1700009|CXHS1700009|呋喹替尼胶囊（CXHS1700008-09）申请上市技术审评报告.pdf
858a68a6589160e06dcfa5a179c41333|CXSS1700010|CXSS1700010|口服Ⅰ型Ⅲ型脊髓灰质炎减毒活疫苗（人二倍体细胞）（CXSS1700010）申请上市技术审评报告.pdf
37e5b6b6e42981973c493e569b9125e8|CXSS1700011|CXSS1700011|Ⅰ型Ⅲ型脊髓灰质炎减毒活疫苗糖丸（人二倍体细胞）（CXSS1700011）-申请上市技术审评报告.pdf
334e1b298cd556cace689f53c954774c|JXSS1700006|JXSS1700006|JXSS1700006-9.pdf
e55a18c6ddc6b3da7bc7cb525f2ceb68|JXSS1700007|JXSS1700007|JXSS1700006-9.pdf
eb39a04e3bc72e919aa54b1595b08a33|JXSS1700008|JXSS1700008|JXSS1700006-9.pdf
e8568522ee36706c035b9ddba470676e|JXSS1700009|JXSS1700009|JXSS1700006-9.pdf
4568289019d49f2f7d2a7daf35c5371e|JXSL1700032|JXSL1700032|依库珠单抗注射液（JXSL1700032）申请上市技术审评报告.pdf
7f0e271dc1dd5c4d34039f97bdfbbdd1|JXHS1700030|JXHS1700030|JXHS1700030.pdf
cabcc6bf4cd320710eec858efc7597b4|JXHS1700031|JXHS1700031|JXHS1700031.pdf
cbec8c465be689ad509d3e4b033440de|JXHS1700028|JXHS1700028|JXHS1700028.pdf
c9dd84fa783efa6f1d514c921e8e7cd0|JXHS1700029|JXHS1700029|JXHS1700028.pdf
6e1c0600cdd0eee1e3c79fa10cc184d2|JXHL1700107|JXHL1700107|曲氟尿苷替匹嘧啶片（JXHL1700107-108）申请上市技术审评报告.pdf
3345fe148fee7b5702a1c39e25850d44|JXHL1700108|JXHL1700108|曲氟尿苷替匹嘧啶片（JXHL1700107-108）申请上市技术审评报告.pdf
acb4813e9f7105d8dc58eec82094f6bf|CXSS1600003|CXSS1600003|门冬胰岛素注射液(CXSS1600003）申请上市技术审评报告.pdf
829044285624adf83d865193f8ae543c|JXSL1700022|JXSL1700022|JXSL1700022.pdf
8a91490313a004ab4868cbfa44dbbb09|JXHS1700024|JXHS1700024|茚达特罗格隆溴铵吸入粉雾剂用胶囊（JXHS1700024）申请上市技术审评报告.pdf
35393fc5988256a06c5bb82932bf8d05|CXSS1700008|CXSS1700008|Sabin株脊髓灰质炎灭活疫苗（Vero细胞）（CXSS1700008）-申请上市技术审评报告.pdf
0864534abe10f977be1bd2c5089742e2|JXHS1700022|JXHS1700022|乌美溴铵维兰特罗吸入粉雾剂（JXHS1700022）申请上市技术审评报告.pdf
b71b72b0173ed5bc26b6fb0ef6039e3c|JXSS1700004|JXSS1700004|JXSS1700004.pdf
8ddb89d3e827608f62284523c9682c1f|JXHL1700080|JXHL1700080|奈妥匹坦帕洛诺司琼胶囊(JXHL1700080)申请上市技术审评报告.pdf
1e536fdf856ae1e1be8006b50e9e3ee3|JXHS1700020|JXHS1700020|乙磺酸尼达尼布软胶囊（JXHS1700020-21）申请上市技术审评报告.pdf
e18ffdbad3bc73381c359eb454790568|JXHS1700021|JXHS1700021|乙磺酸尼达尼布软胶囊（JXHS1700020-21）申请上市技术审评报告.pdf
33e9bc68e8138fc9ddeaca353cc3b5c6|JXHS1700019|JXHS1700019|JXHS1700019.pdf
4053a61cf5707b6c4437db6388f00993|JXHS1700018|JXHS1700018|盐酸帕洛诺司琼注射液(JXHS1700018)申请上市技术审评报告.pdf
5e413fe79a60aae57cea02f106b8c244|JXSS1700002|JXSS1700002|JXSS1700002-003.pdf
c673b311205fdec08a90a63e93298542|JXHS1700017|JXHS1700017|注射用盐酸苯达莫司汀（JXHS1700017）申请上市技术审评报告.pdf
0680b02e4fedf07f48e6131e31833783|JXSS1700003|JXSS1700003|JXSS1700002-003.pdf
be9f8f58bdd058bde1c9c8cc087f2ab5|JXSS1700001|JXSS1700001|JXSS1700001.pdf
01c796df52cdd8c4a425a84f291ea873|CXSS1700005|CXSS1700005|硫培非格司亭注射液（CXSS1700005）申请上市技术审评报告.pdf
5b2ce070b0f3e4cc5408a39ed5f1a0ba|JXHS1700014|JXHS1700014|达塞布韦钠片（JXHS1700015）申请上市技术审评报告.pdf
12e4d1daf0ce23db28939589158c2b08|JXHS1700015|JXHS1700015|达塞布韦钠片（JXHS1700015）申请上市技术审评报告.pdf
d957f1934199ec04c4557cb39001c00e|CXSS1700001|CXSS1700001|乙型肝炎人免疫球蛋白（CXSS1700001）-申请上市技术审评报告.pdf
8213f570e8953c49a9563cfb9ca92bfa|CXSS1700002|CXSS1700002|乙型肝炎人免疫球蛋白（CXSS1700002）-申请上市技术审评报告.pdf
5c164191366bf88f4ef44e8a31d4f831|CXHS1700002|CXHS1700002|盐酸安罗替尼胶囊（CXHS1700002~4）申请上市技术审评报告.pdf
678a1470849d63260d1f7f16bd4283a0|CXHS1700003|CXHS1700003|盐酸安罗替尼胶囊（CXHS1700002~4）申请上市技术审评报告.pdf
7682d3f95cf25c6e51f940aa6109c3bb|CXHS1700004|CXHS1700004|盐酸安罗替尼胶囊（CXHS1700002~4）申请上市技术审评报告.pdf
cec9b4f6e3b5412c2bb4a65265977aa7|JXHS1700011|JXHS1700011|索磷布韦片（JXHS1700011）申请上市技术审评报告.pdf
b284bb7c52b671ba9f40c26fa295c2c4|JXHL1700024|JXHL1700024|司来帕格片（JXHL1700024-31）申请上市技术审评报告.pdf
d42a56366bbc5bd6f4d6919d16aec445|JXHL1700025|JXHL1700025|司来帕格片（JXHL1700024-31）申请上市技术审评报告.pdf
5dc074e887e17d92aa85614935ba88c2|JXHL1700026|JXHL1700026|司来帕格片（JXHL1700024-31）申请上市技术审评报告.pdf
9344b9038893e2e06a8a6a48e3079637|JXHL1700027|JXHL1700027|司来帕格片（JXHL1700024-31）申请上市技术审评报告.pdf
d369e413f4d361376c7f9c8274ef73d0|JXHL1700028|JXHL1700028|司来帕格片（JXHL1700024-31）申请上市技术审评报告.pdf
d5a46431a24e89fc02bf2571526fff77|JXHL1700029|JXHL1700029|司来帕格片（JXHL1700024-31）申请上市技术审评报告.pdf
4709d08a17d463dcd5185089c4202cdc|JXHL1700030|JXHL1700030|司来帕格片（JXHL1700024-31）申请上市技术审评报告.pdf
b6cd69a110d1a17d663f87306937b7a4|JXHL1700031|JXHL1700031|司来帕格片（JXHL1700024-31）申请上市技术审评报告.pdf
76bf87018d435e031e86c84d10aa800d|JXHS1700009|JXHS1700009|丁丙诺啡纳洛酮舌下片（JXHS1700009-10）申请上市技术审评报告.pdf
9edfbd438fd2f37c53f198462c5ca8ab|JXHS1700010|JXHS1700010|丁丙诺啡纳洛酮舌下片（JXHS1700009-10）申请上市技术审评报告.pdf
f608d534d9d60e4129a2767c8278a10c|JXHS1700001|JXHS1700001|拉莫三嗪分散片（JXHS1700001）申请上市技术审评报告.pdf
3a7738953776ac4260bf1f771934a53e|JXSL1700009|JXSL1700009|依洛硫酸酯酶α注射液（JXSL1700009）申请上市技术审评报告.pdf
1815629ff3b6aac7bf5b3efba5ec2b1b|JXHS1700005|JXHS1700005|甲磺酸奥希替尼片（JXHS1700005-6）申请上市技术审评报告.pdf
ca60387e3084386f0135a736bcdba82f|JXHS1700006|JXHS1700006|甲磺酸奥希替尼片（JXHS1700005-6）申请上市技术审评报告.pdf
81857398ac06984cd872102a7a287820|JXHS1600079|JXHS1600079|糠酸氟替卡松维兰特罗吸入粉雾剂(II-III)（JXHS1600079-80）申请上市技术审评报告.pdf
2583d41f8cb5ef5f1c896b6438bb2292|JXHS1600080|JXHS1600080|糠酸氟替卡松维兰特罗吸入粉雾剂(II-III)（JXHS1600079-80）申请上市技术审评报告.pdf
08c19c62fba2736649c6da3fcccc7305|JXHS1600077|JXHS1600077|多替阿巴拉米片（JXHS1600077）申请上市技术审评报告.pdf
5b33d91df37677c9fa0b58d1f935e603|JXSS1600009|JXSS1600009|注射用拉布立海 JXSS1600009-申请上市技术审评报告.pdf
3b64bd87e50eb99fd6be77d98dc71209|JXHS1600083|JXHS1600083|沙库巴曲缬沙坦钠片（JXHS1600083～85）申请上市技术审评报告.pdf
bef5211cdfc9f09ce4afda86c285a3de|JXHS1600084|JXHS1600084|沙库巴曲缬沙坦钠片（JXHS1600083～85）申请上市技术审评报告.pdf
f7c1a171519ddd5696fe55886d5f4e3f|JXHS1600085|JXHS1600085|沙库巴曲缬沙坦钠片（JXHS1600083～85）申请上市技术审评报告.pdf
8b733cf36bf68eed76cc229dfd1d002c|CXHS1600012|CXHS1600012|达诺瑞韦钠片（CXHS1600012）申请上市技术审评报告.pdf
cdebee0b0ae9398592a06d3b5897770f|CXSS1500020|CXSS1500020|培集成干扰素α-2注射液（CXSS1500020）申请上市技术审评报告.pdf
d556d691025b1beff6b40cd52113e8ec|JXHS1600073|JXHS1600073|氢溴酸伏硫西汀片（JXHS1600073-76）申请上市技术审评报告.pdf
5d5435affb6f4351176c62a94d26b0e8|JXHS1600075|JXHS1600075|氢溴酸伏硫西汀片（JXHS1600073-76）申请上市技术审评报告.pdf
15d84cfbbc7e3e6a5273fbfd85465eb3|JXHS1600072|JXHS1600072|奥达特罗吸入喷雾剂 （JXHS1600072）申请上市技术审评报告.pdf
9c0849c2fc26ce141b0d5054a3bfdf15|JXHS1600074|JXHS1600074|氢溴酸伏硫西汀片（JXHS1600073-76）申请上市技术审评报告.pdf
1d784986986a023271dcd745d22f14d4|JXHS1600076|JXHS1600076|氢溴酸伏硫西汀片（JXHS1600073-76）申请上市技术审评报告.pdf
c484055ae6f37132c34cc5cda7bf3f2d|JXHL1600141|JXHL1600141|注射用盐酸美法仑（JXHL1600141）申请上市技术审评报告.pdf
715826c411096626a6fb0315c424c22f|JXHS1600071|JXHS1600071|马昔腾坦片（JXHS1600071）申请上市技术审评报告.pdf
9bb784f8684f531723ee0a3abb95280e|JXSS1600008|JXSS1600008|注射用伊米苷酶（JXSS1600008）申请上市技术审评报告.pdf
cd1dba6ea00db4eca0b39f913c15366c|JXHL1600134|JXHL1600134|索磷布韦维帕他韦片（JXHL1600134）申请上市技术审评报告.pdf
5c66f09aa238557ebfba2caeb814f5ec|JXHS1600067|JXHS1600067|阿舒瑞韦软胶囊（JXHS1600067）申报上市注册技术审评报告.pdf
495b1b183d607484e17d770dd42a0ca2|JXHS1600068|JXHS1600068|盐酸达拉他韦片(JXHS1600068)申请上市注册技术审评报告.pdf
a2e9887bf0d57d5fc1d28693d6d2982e|JXHS1600064|JXHS1600064|西美瑞韦胶囊（JXHS1600064）申请上市技术审评报告.pdf
48bc4ed9843d5f6450513f3be62ad34c|JXHS1600066|JXHS1600066|伊布替尼胶囊（JXHS1600066）申请上市技术审评报告.pdf
17a865f36ba539b70d2e9cc96faa2276|CXSS1600008|CXSS1600008|四价流感病毒裂解疫苗( CXSS1600008)上市公开技术审评报告.pdf
e6b4e1c81b78607501d7e00532f5f993|JXHS1600054|JXHS1600054|卡格列净片 （JXHS1600054-55）申请上市技术审评报告.pdf
2e8e787965b2b884ba77bddacd9c5f45|JXHS1600055|JXHS1600055|卡格列净片 （JXHS1600054-55）申请上市技术审评报告.pdf
cf0336cae940e0ebc2d9db405eccd6ac|JXHL1600078|JXHL1600078|恩曲他滨磷丙替诺福韦片（JXHL1600078～79）申请上市技术审评报告.pdf
fba9da845f338ea81b1e48fc12ec0d0f|JXHL1600079|JXHL1600079|恩曲他滨磷丙替诺福韦片（JXHL1600078～79）申请上市技术审评报告.pdf
6ad9f10e079c98c2ad07f048bf99083e|JXHL1600072|JXHL1600072|枸橼酸伊沙佐米胶囊（JXHL1600072-74）申请上市技术审评报告.pdf
14b0f5a5fd5964a1e7017c96eb5986ed|JXHL1600073|JXHL1600073|枸橼酸伊沙佐米胶囊（JXHL1600072-74）申请上市技术审评报告.pdf
924401ba43408ded1f4f93d0f9835da7|JXHL1600074|JXHL1600074|枸橼酸伊沙佐米胶囊（JXHL1600072-74）申请上市技术审评报告.pdf
cdcb4144c6ed76c4a6467e11692cb47b|JXSL1600036|JXSL1600036|注射用重组人凝血因子VIII(JXSL1600036)-申请上市技术审评报告.pdf
d972eda9c94fc76b619f76945a4d3c6f|JXSL1600037|JXSL1600037|注射用重组人凝血因子VIII(JXSL1600037)-申请上市技术审评报告.pdf
83e4234334ddcbb9a31813e504aa5745|JXSL1600038|JXSL1600038|注射用重组人凝血因子VIII(JXSL1600038)-申请上市技术审评报告.pdf
73c5c176e8635b08cce36ed63a24c2f6|JXSL1600039|JXSL1600039|注射用重组人凝血因子VIII(JXSL1600039)-申请上市技术审评报告.pdf
c38947e18ba901755c7e0f41cef1c479|JXSL1600040|JXSL1600040|注射用重组人凝血因子VIII(JXSL1600040)-申请上市技术审评报告.pdf
b0df8931e8c94ffd35ee1224407d56f3|JXSL1600041|JXSL1600041|注射用重组人凝血因子VIII(JXSL1600041)-申请上市技术审评报告.pdf
0fb6145151c5f08fe7f15ed205b38243|CXHS1500145|CXHS1500145|注射用艾普拉唑钠（CXHS1500145）申请上市技术审评报告.pdf
6bbcd6566ab722c5fbfa384bf409d9e9|CXHS1500163|CXHS1500163|复方氨基酸(19)丙谷二肽注射液（CXHS1500163）申请上市技术审评报告.pdf
e0fc86bbaa99260cfc3ec01513d0ca70|JXHS1600050|JXHS1600050|恩格列净片 （JXHS1600050-51）申请上市技术审评报告.pdf
f8ad49d81dab04f32dbf3c35b4186147|JXHS1600051|JXHS1600051|恩格列净片 （JXHS1600050-51）申请上市技术审评报告.pdf
a38135dfe72524a15d357e060f2b82d4|JXHS1600049|JXHS1600049|注射用艾塞那肽微球（JXHS1600049）申请上市技术审评报告.pdf
64100ae8eebe153e02a14f7e104b9b27|JXHS1600048|JXHS1600048|格隆溴铵吸入粉雾剂用胶囊（JXHS1600048）申请上市技术审评报告.pdf
8ccaa89fa18ad332b5d7dbb09c75d5de|JXHS1600042|JXHS1600042|利司那肽注射液（JXHS1600042-44）申请上市技术审评报告.pdf
fd093b6ea252c55ff5cc7da15071f0b6|JXHS1600043|JXHS1600043|利司那肽注射液（JXHS1600042-44）申请上市技术审评报告.pdf
09b574f3bc1fdcaaf1b75fd699cbf864|JXHS1600044|JXHS1600044|利司那肽注射液（JXHS1600042-44）申请上市技术审评报告.pdf
f0dbe45e242e85f294f1170128e99176|JXSS1600002|JXSS1600002|托珠单抗注射液（JXSS1600002-4）申请上市技术审评报告.pdf
434ff283d052d930a190e28114079b84|JXSS1600003|JXSS1600003|托珠单抗注射液（JXSS1600002-4）申请上市技术审评报告.pdf
920d3c20fa7438a8d6cf2131d5fd2697|JXSS1600004|JXSS1600004|托珠单抗注射液（JXSS1600002-4）申请上市技术审评报告.pdf
2e4e91962d5eb01a350c29bdec9e914f|JXHS1600022|JXHS1600022|沙库巴曲缬沙坦钠片（JXHS1600021～23）申请上市技术审评报告.pdf
4ed7291657db83e62db690c991262e1f|JXHS1600023|JXHS1600023|沙库巴曲缬沙坦钠片（JXHS1600021～23）申请上市技术审评报告.pdf
ab8fec5f344df6553fd9f1c021c78b96|JXHS1600041|JXHS1600041|替米沙坦氨氯地平片（JXHS1600041）申请上市技术审评报告.pdf
ef9a74747f9e15a6ceeb941ac836aacd|JXHS1600039|JXHS1600039|维莫非尼片（JXHS1600039）申请上市技术审评报告.pdf
8a3ca97907c5df93f15fb6910b5c01cd|JXHS1600033|JXHS1600033|利奥西呱片(JXHS1600033，JXHS1600035-38) 申请上市技术审评报告.pdf
5a4d762d72643cb695168a8c568aa7e3|JXHS1600035|JXHS1600035|利奥西呱片(JXHS1600033，JXHS1600035-38) 申请上市技术审评报告.pdf
2a599b7b7bdf979d750d88a8e80088c3|JXHS1600036|JXHS1600036|利奥西呱片(JXHS1600033，JXHS1600035-38) 申请上市技术审评报告.pdf
c1b52ab5625c95c58693781c31b72ed0|JXHS1600037|JXHS1600037|利奥西呱片(JXHS1600033，JXHS1600035-38) 申请上市技术审评报告.pdf
24d174aa6995cf17e7aa12d6aa0317aa|JXHS1600038|JXHS1600038|利奥西呱片(JXHS1600033，JXHS1600035-38) 申请上市技术审评报告.pdf
2f5d01af26ead0e3b149d99ad8022d8d|JXSL1600015|JXSL1600015|依达赛珠单抗注射液（JXSL1600015）申请上市技术审评报告.pdf
09aae182c903b7bcab12153ad3e626b2|CXHS1500176|CXHS1500176|碳酸氢钠林格注射液（CXHS1500176-177）申请上市技术审评报告.pdf
3135215523ccf9f70c0d6c5fbd24e461|CXHS1500177|CXHS1500177|碳酸氢钠林格注射液（CXHS1500176-177）申请上市技术审评报告.pdf
587646c7a23a7b60f2b79f0ebddeff48|JXHS1600028|JXHS1600028|利伐沙班片（JXHS1600028、29、31、32）申请上市技术审评报告.pdf
6dd525c4b6c0be5a9c6fa4b7c7ed68a6|JXHS1600031|JXHS1600031|利伐沙班片（JXHS1600028、29、31、32）申请上市技术审评报告.pdf
93796f43cca6b70879b6bd3827bca57b|JXHS1600029|JXHS1600029|利伐沙班片（JXHS1600028、29、31、32）申请上市技术审评报告.pdf
518c9398d80182736464b67dab5f0c74|JXHS1600032|JXHS1600032|利伐沙班片（JXHS1600028、29、31、32）申请上市技术审评报告.pdf
a6879cc909e319a71d4882fe9ef15f79|JXHS1600024|JXHS1600024|来那度胺胶囊（JXHS1600024-27）申请上市技术审评报告.pdf
f31189acde48792d7ff5ebed543c6e3b|JXHS1600025|JXHS1600025|来那度胺胶囊（JXHS1600024-27）申请上市技术审评报告.pdf
b3beca063126d86b5e4fabf9956738f4|JXHS1600026|JXHS1600026|来那度胺胶囊（JXHS1600024-27）申请上市技术审评报告.pdf
34638ed86858616201e6c41dc820ec2a|JXHS1600027|JXHS1600027|来那度胺胶囊（JXHS1600024-27）申请上市技术审评报告.pdf
46917dc3b515a43caf738c7f3a8ad496|JXHS1600012|JXHS1600012|富马酸喹硫平缓释片   ( JXHS1600012-15)  申请上市技术审评报告.pdf
fe61ae3717b700c430210d78efc9da6e|JXHS1600015|JXHS1600015|富马酸喹硫平缓释片   ( JXHS1600012-15)  申请上市技术审评报告.pdf
814d535ee0ce589b2303875930b0417b|JXHS1600021|JXHS1600021|沙库巴曲缬沙坦钠片（JXHS1600021～23）申请上市技术审评报告.pdf
9275b5f8ebfc3273a59886c33bf81ef6|JXHL1600033|JXHL1600033|达芦那韦考比司他片（JXHL1600033）申请上市技术审评报告.pdf
741d8ec19a795e4656f768d43f097454|JXHS1600018|JXHS1600018|维格列汀片（JXHS1600018-19）申请上市技术审评报告.pdf
fc722ef8de5da81e6fcee89ca34bacc9|JXHS1600019|JXHS1600019|维格列汀片（JXHS1600018-19）申请上市技术审评报告.pdf
1c7eae6fe35dac7038b729ee6950b862|JXHS1600016|JXHS1600016|舒更葡糖钠注射液（JXHS1600016-17）申请上市技术审评报告.pdf
c56104e4eb23c6fbdb0d68c788283d87|JXHS1600017|JXHS1600017|舒更葡糖钠注射液（JXHS1600016-17）申请上市技术审评报告.pdf
0acbf45ea7fcbb92291833c2f9088196|JXHS1600008|JXHS1600008|马来酸阿法替尼片（JXHS1600008~11）申请上市技术审评报告.pdf
f2f356618976f5987d1e84a3f8a1e730|JXHS1600009|JXHS1600009|马来酸阿法替尼片（JXHS1600008~11）申请上市技术审评报告.pdf
929a83111691a615dcacbee87236fa9b|JXHS1600010|JXHS1600010|马来酸阿法替尼片（JXHS1600008~11）申请上市技术审评报告.pdf
ce6335e233b08763f05c6aedb51d9aaf|JXHS1600011|JXHS1600011|马来酸阿法替尼片（JXHS1600008~11）申请上市技术审评报告.pdf
a4711bb2a3e1194af09dc380e81a65f4|JXSS1600001|JXSS1600001|口服五价重配轮状病毒减毒活疫苗(Vero细胞) （JXSS1600001)申请上市技术审评报告.pdf
14a4f41ced68389a241d318b7b587846|JXHL1600019|JXHL1600019|二甲双胍恩格列净片(JXHL1600019、20、21、23、24)申请上市技术审评报告.pdf
48da39eb201e84c8497d082804de65b1|JXHL1600020|JXHL1600020|二甲双胍恩格列净片(JXHL1600019、20、21、23、24)申请上市技术审评报告.pdf
01f92a0f6aa47370c2df1800a409882d|JXHL1600021|JXHL1600021|二甲双胍恩格列净片(JXHL1600019、20、21、23、24)申请上市技术审评报告.pdf
0329aa4ff5fc39ba43876fb57844c830|JXHL1600023|JXHL1600023|二甲双胍恩格列净片(JXHL1600019、20、21、23、24)申请上市技术审评报告.pdf
c3862a25395dac92e3d4b2b4574d3bb4|JXHL1600024|JXHL1600024|二甲双胍恩格列净片(JXHL1600019、20、21、23、24)申请上市技术审评报告.pdf
fbd1a820b16b658cbf428bcd48b5ddc5|JXHL1600006|JXHL1600006|利那洛肽胶囊（JXHL1600006、JXHL1600007）申请上市技术审评报告.pdf
71d29ab5f04a35142977c4c6e1995551|JXHL1600009|JXHL1600009|艾考恩丙替片（JXHL1600009）申请上市技术审评报告.pdf
cdbb86395292115dbcc9ac9c2e9a74f2|JXHL1600007|JXHL1600007|利那洛肽胶囊（JXHL1600006、JXHL1600007）申请上市技术审评报告.pdf
7ce6df8f0a00c3674939f32985f7289b|JXHL1500330|JXHL1500330|棕榈帕利哌酮酯注射液(3M)（JXHL1500330-333）申请上市技术审评报告.pdf
dc5e4cc836d069acff107eda143edc81|JXHL1500331|JXHL1500331|棕榈帕利哌酮酯注射液(3M)（JXHL1500330-333）申请上市技术审评报告.pdf
a67dd0de426f14e7bf9767cd3548b206|JXHL1500332|JXHL1500332|棕榈帕利哌酮酯注射液(3M)（JXHL1500330-333）申请上市技术审评报告.pdf
cb991b5d9b7118e29c442bcb74846c2d|JXHL1500333|JXHL1500333|棕榈帕利哌酮酯注射液(3M)（JXHL1500330-333）申请上市技术审评报告.pdf
a796aeaada84cba070d6682fe8c18968|JXHS1600001|JXHS1600001|米拉贝隆缓释片（JXHS1600001、02）申请上市技术审评报告.pdf
8667d4158122bb1805739f36a45514a9|JXHS1600002|JXHS1600002|米拉贝隆缓释片（JXHS1600001、02）申请上市技术审评报告.pdf
34f3fd37d8c38144efa7aa2b41d073bf|JXHS1500129|JXHS1500129|盐酸鲁拉西酮片（JXHS1500129）申请上市 技术审评报告.pdf
ed41b3910ae75b922f4895909c187c5b|JXHS1500126|JXHS1500126|枸橼酸托法替布片（JXHS1500126）公开技术审评报告.pdf
c8f3313d1b581d816eae91edfdb9a400|JXHS1500123|JXHS1500123|盐酸度洛西汀肠溶胶囊（JXHS1500123-124）申请上市技术审评报告.pdf
11c42eeb85e1c94e8b17a85b0007b64b|JXHS1500124|JXHS1500124|盐酸度洛西汀肠溶胶囊（JXHS1500123-124）申请上市技术审评报告.pdf
6b9ad2450b24b5190bdc3156c341d3f3|JXHS1500112|JXHS1500112|达格列净片（JXHS1500112-113）申请上市技术审评报告.pdf
d70358ce5fa15ef1f567e1a0837b9de1|JXHS1500113|JXHS1500113|达格列净片（JXHS1500112-113）申请上市技术审评报告.pdf
09d7d5d35d9fa0a07b81dd8a5eaf123b|JXHS1500114|JXHS1500114|磷酸芦可替尼片（JXHS1500114-19）申请上市技术审评报告.pdf
5f6cc02115d5bc818ca035d5e9fd0f85|JXHS1500116|JXHS1500116|磷酸芦可替尼片（JXHS1500114-19）申请上市技术审评报告.pdf
8d3cc2608411901fefef5827ad7d4ccd|JXHS1500118|JXHS1500118|磷酸芦可替尼片（JXHS1500114-19）申请上市技术审评报告.pdf
d91f230ef8e39e804673b5f04c280221|JXHS1500103|JXHS1500103|瑞戈非尼片（JXHS1500103）申请上市技术审评报告.pdf
c260c0fa19884dcb8f48ac84aeabcb2b|JXHS1500108|JXHS1500108|JXHS1500108.pdf
9c44c06643f4e7d38d02d44f0a0b6f90|JXHS1500109|JXHS1500109|盐酸厄洛替尼片(JXHS1500109-10)-申请上市技术审评报告.pdf
e2a35d2a49b67797ad991d9f167d3109|JXHS1500110|JXHS1500110|盐酸厄洛替尼片(JXHS1500109-10)-申请上市技术审评报告.pdf
ab1f8ee6e809ae7660425c7887c70813|JXHS1500111|JXHS1500111|JXHS1500111.pdf
f58785d287ff688947ea3185742ce034|JXHS1500115|JXHS1500115|磷酸芦可替尼片（JXHS1500114-19）申请上市技术审评报告.pdf
a3b84ff87aa3e6139b7feacd32242aae|JXHS1500117|JXHS1500117|磷酸芦可替尼片（JXHS1500114-19）申请上市技术审评报告.pdf
ec5e2cfeb04a0f6c25956ddecd0fa9df|JXHS1500119|JXHS1500119|磷酸芦可替尼片（JXHS1500114-19）申请上市技术审评报告.pdf
8568d86203984b5c1fbe24ede219adfe|JXSS1500015|JXSS1500015|注射用英夫利西单抗（JXSS1500015）申报上市注册申请技术审评报告.pdf
ea80cd1fe404248300a55d6545a10648|JXHS1500100|JXHS1500100|非布司他片（JXHS1500100-101）申请上市技术审评报告.pdf
3cc3833861cb3a2a3cae2656132726c3|JXHS1500101|JXHS1500101|非布司他片（JXHS1500100-101）申请上市技术审评报告.pdf
9fffff19ad78a98e7cd15672e2da6605|JXHL1500275|JXHL1500275|注射用全氟丁烷微球（JXHL1500275）申请上市技术审评报告.pdf
172f7cb9af9f58e26eb0324c63df9ed6|JXHL1500266|JXHL1500266|哌柏西利胶囊(JXHL1700151-153、JXHL1500266-268)申请上市技术审评报告.pdf
5b12f6a7b1d11a0f5bb3991fb23fdc4c|JXHL1500267|JXHL1500267|哌柏西利胶囊(JXHL1700151-153、JXHL1500266-268)申请上市技术审评报告.pdf
fdf8fd1a06bf0ee08a0ee73362f7c456|JXHL1500268|JXHL1500268|哌柏西利胶囊(JXHL1700151-153、JXHL1500266-268)申请上市技术审评报告.pdf
bcb67c72437496aa90c2919e57cdce4c|CXHS1500147|CXHS1500147|注射用盐酸兰地洛尔（CXHS1500147）申请上市技术审评报告.pdf
e622abbe28fe001a2858002cfc9749d3|JXHS1500092|JXHS1500092|拉莫三嗪分散片（JXHS1500092-96）申请上市技术审评报告.pdf
0b440727c1eb2782d6b2caecf778477d|JXHS1500093|JXHS1500093|拉莫三嗪分散片（JXHS1500092-96）申请上市技术审评报告.pdf
d4807f4c5120b2b1939085ae4dfb55ec|JXHS1500094|JXHS1500094|拉莫三嗪分散片（JXHS1500092-96）申请上市技术审评报告.pdf
fbc3d518aa23420f6ce819caf5665f52|JXHS1500095|JXHS1500095|拉莫三嗪分散片（JXHS1500092-96）申请上市技术审评报告.pdf
88dc14b67fac491d4df7128578e4d2b0|JXHS1500096|JXHS1500096|拉莫三嗪分散片（JXHS1500092-96）申请上市技术审评报告.pdf
c26341d32d58d7a97aa3136f2a8c913e|CXHS1500143|CXHS1500143|盐酸决奈达隆片（CXHS1500143）申请上市技术审评报告.pdf
f82c6141e8e915223eda7599c283f68b|CXHS1400149|CXHS1400149|奈韦拉平齐多拉米双夫定片（CXHS1400149）申请上市技术审评报告.pdf
0395dd4e1c9adcd85c8245ceef5ff6b9|JXHS1500097|JXHS1500097|交联玻璃酸钠注射液（JXHS1500097）公开技术审评报告.pdf
9c2d49b1af73fc6b63ff3135a2bbdafa|CXHS1500126|CXHS1500126|氨氯地平叶酸片（CXHS1500126-127）申请上市技术审评报告.pdf
835f2949190bf08316aee532b6872ebd|CXHS1500127|CXHS1500127|氨氯地平叶酸片（CXHS1500126-127）申请上市技术审评报告.pdf
a9022cac7ef50855ad4e4c5777b81f86|JXHS1500091|JXHS1500091|普乐沙福注射液（JXHS1500091、JXHL1700161）申请上市技术审评报告.pdf
f044cdf4b7d7286aa12ffb85fc81a74c|JXSS1500010|JXSS1500010|德谷胰岛素注射液（JXSS1500010-11）申请上市技术审评 报告.pdf
0531172e9e958620860f9130d31b1ea4|JXSS1500011|JXSS1500011|德谷胰岛素注射液（JXSS1500010-11）申请上市技术审评 报告.pdf
88033dd47bab29154ce7b5990f98182b|CXSS1500016|CXSS1500016|重组人胰岛素注射液(CXSS1500016)申请上市技术审评报告.pdf
890d33fd39e7b1e530654c8f4a2538a9|CXSS1500014|CXSS1500014|CXSS1500014.pdf
d54e66b7a7551fb6a253741241d69853|JXHS1500081|JXHS1500081|罗替高汀透皮贴片（JXHS1500081-84）申请上市技术审评报告.pdf
6969258b1429bba46bc28f190882384d|JXHS1500082|JXHS1500082|罗替高汀透皮贴片（JXHS1500081-84）申请上市技术审评报告.pdf
8ea7cd4f4235515d7d03e9381a4f432a|JXHS1500083|JXHS1500083|罗替高汀透皮贴片（JXHS1500081-84）申请上市技术审评报告.pdf
702105af3d4154643cfa19e4bef21754|JXHS1500084|JXHS1500084|罗替高汀透皮贴片（JXHS1500081-84）申请上市技术审评报告.pdf
6327d3dd288daf2ee57d23104e1c0a7c|CXSS1500009|CXSS1500009|人纤维蛋白原(CXSS1500009)-申请上市技术审评报告.pdf
adc44b78e5d2c58b42e3798f2076e060|CXSS1500010|CXSS1500010|吸附无细胞百白破联合疫苗（CXSS1500010）-申请上市技术审评报告.pdf
2fe166cbb0fde370b70247b3e8bcf201|JXHS1500076|JXHS1500076|拉考沙胺片（JXHS1500076-79)申请上市技术审评报告.pdf
a56b0a852bba736a7b3643c91512abc8|JXHS1500077|JXHS1500077|拉考沙胺片（JXHS1500076-79)申请上市技术审评报告.pdf
a0d7c59b0e90b929d4875e0773d41772|JXHS1500078|JXHS1500078|拉考沙胺片（JXHS1500076-79)申请上市技术审评报告.pdf
12766503a860f58995b18da2486ef04f|JXHS1500079|JXHS1500079|拉考沙胺片（JXHS1500076-79)申请上市技术审评报告.pdf
ae1c116472b18f0ae2610a550853d549|CXHS1500043|CXHS1500043|注射用比伐芦定（CXHS1500043）申请上市技术审评报告.pdf
a2ddd9801c085883cb0655c4a227eab9|JXHS1500062|JXHS1500062|JXHS1500062.pdf
cefe5b5a5822d768777dbf0d04024627|CXSS1500006|CXSS1500006|贝那鲁肽注射液（CXSS1500006）申请上市技术审评报告.pdf
58de668b34f53e8c2526c8dfab699dbf|JXHS1500058|JXHS1500058|恩曲利替片（JXHS1500058）审评报告.pdf
e92d01cc386352e68d255efb4911af73|JXSS1500006|JXSS1500006|JXSS1500007.pdf
74190ea32f31338cf196a01b4f377bff|JXSS1500007|JXSS1500007|JXSS1500007.pdf
1fe4fd163451e799abdddb984995e41e|JXHS1500046|JXHS1500046|培唑帕尼片（JXHS1500046-47）申请上市技术审评报告.pdf
cd9a96c34dfbad56e33271fac150ffda|JXHS1500047|JXHS1500047|培唑帕尼片（JXHS1500046-47）申请上市技术审评报告.pdf
5d114913f115ba7a2a1c536f5933f19e|JXHS1500042|JXHS1500042|奈韦拉平缓释片（JXHS1500042,JXHS1500043）审评报告.pdf
940f6cce8604a8bb54b2ed4a24929c50|JXHS1500043|JXHS1500043|奈韦拉平缓释片（JXHS1500042,JXHS1500043）审评报告.pdf
d16f8bd3c2b7c33d38f92b6ce4c9dc4d|CXHS1500041|CXHS1500041|盐酸多奈哌齐片   ( CXHS1500041-42)申请上市技术审评报告.pdf
37a7143f412e36a172040355d455f85f|CXHS1500042|CXHS1500042|盐酸多奈哌齐片   ( CXHS1500041-42)申请上市技术审评报告.pdf
c8d79e513a6df98adf05893281ace198|JXHS1500037|JXHS1500037|多替拉韦钠片（JXHS1500037）审评报告.pdf
f239b95dde416461b887c6bf139ea2a1|CXHS1400282|CXHS1400282|利多卡因凝胶贴膏（CXHS1400282）申请上市技术审评报告.pdf
f1c1a600b64a96b1ff637e910d8de0bb|JXHS1500026|JXHS1500026|麦格司他胶囊（JXHS1500026）申请上市技术审评报告.pdf
0a11a5bdcb103c171005ff8841656779|JXHS1500022|JXHS1500022|磷酸西格列汀片（JXHS1500022-24）申请上市技术审评报告.pdf
6a4f124c09eea8f66d3eaf642896955f|JXHS1500023|JXHS1500023|磷酸西格列汀片（JXHS1500022-24）申请上市技术审评报告.pdf
fca8da7946d1f043878dbe4e24a19856|JXHS1500024|JXHS1500024|磷酸西格列汀片（JXHS1500022-24）申请上市技术审评报告.pdf
8639d651104273da17f8679bc206b1c0|CXHS1500016|CXHS1500016|碳酸氢钠林格注射液（CXHS1500016）申请上市技术审评报告.pdf
2994b3eb2ca0ab22f917771ff84ee185|CXHS1400266|CXHS1400266|来那度胺胶囊（CXHS1400266-268）申请上市技术审评报告.pdf
36010f647bc76f6ce3b6d61a0e1a541f|CXHS1400267|CXHS1400267|来那度胺胶囊（CXHS1400266-268）申请上市技术审评报告.pdf
d7b2f5b0fa9be3d75a5c711b15f1c46a|CXHS1400268|CXHS1400268|来那度胺胶囊（CXHS1400266-268）申请上市技术审评报告.pdf
202f8c6b891971e9b219ea2bfad0c389|CXSS1400015|CXSS1400015|CXSS1400015_精蛋白重组人胰岛素注射液(预混30_报告_.pdf
82c7d5daf05a7625070244d9f472d795|JXHS1400131|JXHS1400131|利格列汀二甲双胍片（I、Ⅱ）（JXHS1400131、133）申请上市技术审评报告.pdf
87174dd3c04bdf5745a0825aae218f88|JXHS1400133|JXHS1400133|利格列汀二甲双胍片（I、Ⅱ）（JXHS1400131、133）申请上市技术审评报告.pdf
40120a335e4f76b55bf3fb4644151c37|CXSS1400002|CXSS1400002|门冬胰岛素30注射液（CXSS1400002）上市申请技术审评报告.pdf
0e94e3802cf31d2434d4a387b4cee4c5|CXSS1400023|CXSS1400023|b型流感嗜血杆菌结合疫苗（CXSS1400023）申请上市技术审评报告.pdf
130463ebd5bc7504a1fc976a4206d0db|JXHS1400125|JXHS1400125|注射用阿扎胞苷（JXHS1400125）申请上市技术审评报告.pdf
053451134656ac8ea2e750339b224fca|CXSS1400025|CXSS1400025|AC群脑膜炎球菌多糖疫苗（CXSS1400025）申请上市技术审评报告.pdf
3cc45b396497b598341ce3af000490e5|CXHS1400255|CXHS1400255|富马酸替诺福韦二吡呋酯片（CXHS1400255）申报上市注册申请技术审评报告.pdf
f76474ddaaf6ec5a18c6c2137995c581|CXSS1400024|CXSS1400024|ACYW135群脑膜炎球菌多糖疫苗（CXSS1400024）-申请上市技术审评报告.pdf
3b3023f11f4979f87a36738995086c72|JXHS1400119|JXHS1400119|艾曲泊帕乙醇胺片（JXHS1400118、119）申请上市技术审评报告.pdf
bb161bd5149cca73cdf42b365db96558|JXHS1400118|JXHS1400118|艾曲泊帕乙醇胺片（JXHS1400118、119）申请上市技术审评报告.pdf
59568a943bc623caa55ee7a2724ef387|JXHS1400097|JXHS1400097|JXHS1400097.pdf
f4f5c33294f939eddb792a7c59705381|JXHS1400095|JXHS1400095|JXHS1400095~6.pdf
890d3a13c2e3014c5849e93fe94ac144|JXHS1400096|JXHS1400096|JXHS1400095~6.pdf
c2c56c692cda50ce2caada489c9c969a|CXHS1400212|CXHS1400212|CXHS1400212.pdf
99d3770991f108b3bd53f3963435d422|JXHS1400087|JXHS1400087|JXHS1400087.pdf
fc528384dbd9f6691ff56f7e1167b4ad|JXHS1400081|JXHS1400081|阿昔替尼片（JXHS1400081）审评报告.pdf
1df43aa707869a9c8bc11afe1ed48ff1|JXHS1400080|JXHS1400080|阿昔替尼片（JXHS1400080）审评报告.pdf
bfa2cd14d1188873fc4fc9ba00db355e|CXHS1400189|CXHS1400189|富马酸替诺福韦二吡呋酯片（CXHS1400189）申报上市注册申请技术审评报告.pdf
cc76b1cef069b05d918cbfb7cf718e0d|CXHS1400157|CXHS1400157|富马酸替诺福韦二吡呋酯胶囊（CXHS1400157）申报上市注册申请技术审评报告.pdf
73da794bed6a5715ec6fc97445f0a7f0|JXSS1400007|JXSS1400007|戈利木单抗注射液（JXSS1400007）申请上市技术审评报告.pdf
2d5ba47a0ed00be671f03353a829b08d|JXHS1400056|JXHS1400056|丙酸氟替卡松雾化吸入用混悬液（JXHS1400056）申请上市技术审评报告.pdf
929fec866742e7106b6c4206a8a5a34d|CXHS1400152|CXHS1400152|艾普拉唑肠溶片（CXHS1400152）申请上市技术审评报告.pdf
afc7b2b66eaf4b5cdec57d57aa0ba1b3|JXSS1400006|JXSS1400006|JXSS1400006.pdf
c42efa48251df03cb0a9beb779e146ab|JXSL1400034|JXSL1400034|依那西普注射液（JXSL1400034）申请上市技术审评报告.pdf
939d2ecc133bcefed27026a6681318e0|JXSS1400005|JXSS1400005|注射用奥马珠单抗（JXSS1400005）申请上市技术审评报告.pdf
06264b2836d41581ef0e27becdca772e|JXSS1400003|JXSS1400003|依那西普注射液（JXSS1400003-4）申请上市技术审评报告.pdf
17eb87d9d8309a05bce09dfd44ac2066|JXSS1400004|JXSS1400004|依那西普注射液（JXSS1400003-4）申请上市技术审评报告.pdf
42ec596f34ed065d25ba48d9f14f9798|CXHS1400067|CXHS1400067|左乙拉西坦注射用浓溶液（CXHS1400067）申请上市技术审评报告.pdf
2328d026c090b0ebbb20cb3bfd6c42d8|JXHL1400131|JXHL1400131|特立氟胺片（JXHL1400131、132）申请上市技术审评报告.pdf
3a3fbab44808c8a185bb778ecde698f4|JXHL1400132|JXHL1400132|特立氟胺片（JXHL1400131、132）申请上市技术审评报告.pdf
52636153086e3377d31075b77e19b620|CXSS1400005|CXSS1400005|23价肺炎球菌多糖疫苗（CXSS1400005）申请上市技术审评报告.pdf
01ba3fd2738c5a86a137a3e9d2570e3c|JXSS1400002|JXSS1400002|JXSS1400002.pdf
dd0bec13af0f122caeae820c3632af34|CXHS1400061|CXHS1400061|托伐普坦片（CXHS1400061、62）申请上市技术审评报告.pdf
1e0a362d64015ebcbf32d6949acbba11|CXHS1400062|CXHS1400062|托伐普坦片（CXHS1400061、62）申请上市技术审评报告.pdf
058ddb35127bbd69e306855e4442f664|JXSS1400001|JXSS1400001|13价肺炎球菌多糖结合疫苗 （JXSS1400001）申请上市技术审评报告.pdf
b44b568c589fbbf070979d61dba030be|CXHS1300192|CXHS1300192|注射用前列地尔乳剂（CXHS1300192-93）申请上市技术审评报告.pdf
914b64dcb950919cfdd56f5571ace29f|CXHS1300193|CXHS1300193|注射用前列地尔乳剂（CXHS1300192-93）申请上市技术审评报告.pdf
a941d23017df025ec84043d9784e9baf|CXSS1300028|CXSS1300028|聚乙二醇干扰素α-2b注射液（CXSS1300028）.pdf
efb48bbb79d5898d595653aed2a8df54|CXSS1300023|CXSS1300023|人用狂犬病疫苗(Vero细胞)（CXSS1300023）审评报告.pdf
771d720b05b435c728ddcee0d21dcc57|JXHS1300114|JXHS1300114|甲磺酸雷沙吉兰片（受理号JXHS1300114～115）申请上市技术审评报告.pdf
c287e364089c4e5278af4ec406099c9d|JXHS1300115|JXHS1300115|甲磺酸雷沙吉兰片（受理号JXHS1300114～115）申请上市技术审评报告.pdf
36dfad2f2925a4b60e4911d8b52f404b|CXHS1300287|CXHS1300287|注射用头孢哌酮钠他唑巴坦钠申请上市技术审评报告.pdf
a8421bf5b12c56c4c9d57882b1075665|CXHS1300288|CXHS1300288|注射用头孢哌酮钠他唑巴坦钠申请上市技术审评报告.pdf
fb0a8557c244ff9e658407cd299e0ed8|CXSS1300022|CXSS1300022|吸附破伤风疫苗(Vero细胞) （CXSS1300022）申请上市技术审评报告.pdf
62e45c29751872c9acf2500f258969e9|JXHS1300104|JXHS1300104|左乙拉西坦注射用浓溶液（XHS1300104）申请上市技术审评报告.pdf
d9ba60373bfbe8ed66a7f75848fd95d9|JXHS1300099|JXHS1300099|沙格列汀二甲双胍缓释片（Ⅰ）、（Ⅱ）、（Ⅲ）（JXHS1300099-101）申请上市技术审评报告.pdf
1845d660d24974219b14f9ae7093bd0c|JXHS1300100|JXHS1300100|沙格列汀二甲双胍缓释片（Ⅰ）、（Ⅱ）、（Ⅲ）（JXHS1300099-101）申请上市技术审评报告.pdf
a4d4a92b7fc84a1396e38ed14475d3f0|JXHS1300101|JXHS1300101|沙格列汀二甲双胍缓释片（Ⅰ）、（Ⅱ）、（Ⅲ）（JXHS1300099-101）申请上市技术审评报告.pdf
183d41dd6274e3b2c398b60043013965|CXSS1300021|CXSS1300021|23价肺炎链球菌多糖结合疫苗 (CXSS1300021)申请上市技术审评报告.pdf
019eb35a74e4cc404bd7485e0e2be800|JXHS1300095|JXHS1300095|利斯的明透皮贴剂   ( JXHS1300095-96）申请上市技术审评报告.pdf
3f06546234920791912e97ffa59c0a45|JXHS1300096|JXHS1300096|利斯的明透皮贴剂   ( JXHS1300095-96）申请上市技术审评报告.pdf
0a0ce1e90efa50f14483407a829485ac|JXHS1300072|JXHS1300072|布南色林片( JXHS1300072 ) 申请上市技术审评报告.pdf
c2ca27d68c1c6cc7482767edfdf2f414|CXSS1300020|CXSS1300020|肠道病毒71型灭活疫苗（Vero细胞）（CXSS1300020）申请上市技术审评报告.pdf
686e3f1c9b668b36f3a41bf56102e92b|CXSS1300018|CXSS1300018|肠道病毒71型灭活疫苗（Vero细胞）（CXSS1300018）审评报告.pdf
333fd2eac0928e881578082373233f8a|CXHS1300115|CXHS1300115|苹果酸奈诺沙星胶囊（CXHS1300115）审评报告.pdf
d84c3e9c4afb8928252c9df9797a83d5|CXZS1300008|CXZS1300008|金蓉颗粒（CXZS1300008） 申请上市技术审评报告.pdf
47033ece8720feb3289e49d60e67bae6|CXSS1300015|CXSS1300015|冻干人用狂犬病疫苗(Vero细胞)（CXSS1300015）申报上市注册申请技术审评报告.pdf
4b5255eb0a84820cef4ca3e8b6bbe20c|CXSS1300008|CXSS1300008|肠道病毒71型灭活疫苗（人二倍体细胞）（CXSS1300008）审评报告.pdf
beb5c6e8d689ac493f07fb14eaddb996|JXSS1300004|JXSS1300004|甲氧聚二醇重组人促红素注射液（JXSS1300004~8）申请上市技术审评报告.pdf
41ab47d03a569b3c701396b15c6880db|JXSS1300005|JXSS1300005|甲氧聚二醇重组人促红素注射液（JXSS1300004~8）申请上市技术审评报告.pdf
742ea6bfc01ab86e91461bcac60b92a1|JXSS1300006|JXSS1300006|甲氧聚二醇重组人促红素注射液（JXSS1300004~8）申请上市技术审评报告.pdf
d703f97a5cc85b8f82178743406102e3|JXSS1300007|JXSS1300007|甲氧聚二醇重组人促红素注射液（JXSS1300004~8）申请上市技术审评报告.pdf
bef2c9e9f88b44170ae4c5db93a69534|JXSS1300008|JXSS1300008|甲氧聚二醇重组人促红素注射液（JXSS1300004~8）申请上市技术审评报告.pdf
20213889cc86895770803c024c93c19a|CXSS1300013|CXSS1300013|重组细胞因子基因衍生蛋白注射液（CXSS1300013）申请上市技术审评报告.pdf
31612d2a2e4004a340b01a6fa5585cc6|CXZS1300012|CXZS1300012|小儿荆杏止咳颗粒（CXZS1300012）申请上市技术审评报告.pdf
987813a7c6f2f0afea1a4333578cd1e3|CXZS1300004|CXZS1300004|关黄母颗粒（CXZS1300004）申请上市技术审评报告.pdf
2f78f372d351c6851af7431c7710a731|CXHS1300047|CXHS1300047|西达本胺片（CXHS1300047）审评报告.pdf
e9a93cdab6544dfc6a526817534a6fd2|CXSS1300001|CXSS1300001|甘精胰岛素注射液( CXSS1300001 )上市申请技术审评报告.pdf
047217c4e22b0498785ae27910152578|CXSS1300003|CXSS1300003|脊髓灰质炎减毒活疫苗糖丸（人二倍体细胞）（CXSS1300003）审评报告.pdf
72dd2a3b43dc62f4c258e75faa8c31c7|JXHS1200098|JXHS1200098|JXHS1200098.pdf
d78356f624fb706263fd8854fe4dfa42|CXHS1200164|CXHS1200164|CXHS1200164.pdf
0eb75db5977252f1c2ce66b9895e9f17|CXHS1200165|CXHS1200165|CXHS1200164.pdf
2e01ae022ebd2b717abd75d9f39b9df7|CXSS1200007|CXSS1200007|人免疫球蛋白（CXSS1200007）-申请上市技术审评报告.pdf
4d5eaad0873ddfcfe841d9c5e18150e0|CXSS1200008|CXSS1200008|人免疫球蛋白（CXSS1200008）-申请上市技术审评报告.pdf
984d39e20531766f09999641dbfba2a4|JXHS1200058|JXHS1200058|培哚普利氨氯地平片（JXHS1200056-59）申请上市技术审评报告.pdf
b91baa3fb983fea823ac738f6df1d930|JXHS1200059|JXHS1200059|培哚普利氨氯地平片（JXHS1200056-59）申请上市技术审评报告.pdf
bfe8aa0abaacbea7c5b765768360cad9|JXHS1200056|JXHS1200056|培哚普利氨氯地平片（JXHS1200056-59）申请上市技术审评报告.pdf
35e2e9deee5055941441ca708bc18680|JXHS1200057|JXHS1200057|培哚普利氨氯地平片（JXHS1200056-59）申请上市技术审评报告.pdf
ba7aed094c29ae31467c0a35463a716e|JXSS1200002|JXSS1200002|双价重组人乳头瘤病毒疫苗（16、18型）（JXSS1200002-003)审评报告.pdf
0406ac150906843c7fa86a1fedf4ee62|JXSS1200003|JXSS1200003|双价重组人乳头瘤病毒疫苗（16、18型）（JXSS1200002-003)审评报告.pdf
62d75837caaf77d39405890f6ade9204|CXHS1100238|CXHS1100238|莫达非尼胶囊（CXHS1100238－239） 申请上市技术审评报告.pdf
530ca5ec637cdd1875145a3bbf438de4|CXHS1100239|CXHS1100239|莫达非尼胶囊（CXHS1100238－239） 申请上市技术审评报告.pdf
44f771dd67739210a8242cce20475309|CXZS1100049|CXZS1100049|金花清感颗粒CXZS1100049  公开技术审评报告.pdf
0882e3c649cf35c8890a46bc3fd89b6f|CXHS1100129|CXHS1100129|奥美沙坦酯氨氯地平片（CXHS1100129）申请上市技术审评报告.pdf
d61ac2559614f7a76cf43c6639c9ad66|CXHS1000275|CXHS1000275|缬沙坦片（CXHS1000275-6）申报上市注册申请技术审评报告.pdf
a767644547e45d73f7cff6ca0c6e94ec|CXHS1000276|CXHS1000276|缬沙坦片（CXHS1000275-6）申报上市注册申请技术审评报告.pdf
bcccda63350fccaf087acf0e206fd857|CXHS1000305|CXHS1000305|左旋奥硝唑片临床（CXHS1000305)申请上市技术审评报告.pdf
6ca5248876a9a4bb182295797072a845|CXHS1000028|CXHS1000028|注射用奥拉西坦（CXHS1000028）申请上市技术审评报告.pdf
71427c8c66544a8fbc72674e679bf418|JXSS0900012|JXSS0900012|四价人乳头瘤病毒疫苗（酿酒酵母）（JXSS0900012-13)申请上市技术审评报告.pdf
f7048898354184eebbd3ef411f2049ee|JXSS0900013|JXSS0900013|四价人乳头瘤病毒疫苗（酿酒酵母）（JXSS0900012-13)申请上市技术审评报告.pdf
4219f868d2ff159e8064107b0ffdd00f|CXHS0900125|CXHS0900125|枸橼酸爱地那非片（CXHS0900125）申请上市技术审评报告.pdf
db51a2bb1bce5f16d238fba46b530709|CXSS0800007|CXSS0800007|水痘减毒活疫苗（CXSS0800007）申请上市技术审评报告.pdf
c56d579a0259686d10a1f40a55e2042c|CXZS0700170|CXZS0700170|丹龙口服液（CXZS0700170）申请上市技术审评报告.pdf
